Curriculum Vitae. Douglas Michael Ziedonis, MD, MPH

Curriculum Vitae NAME: ADDRESS: CITIZENSHIP: Douglas Michael Ziedonis, MD, MPH Professor and Chair, Department of Psychiatry University of Massachusetts Medical School & UMass Memorial Health Care 55 Lake Avenue, North Worcester, MA 01655 W: 508-856-3066; Fax: 508-856-2725 Email: Douglas.Ziedonis@umassmemorial.org United States EDUCATION: 1977-1981 B.S. Davidson College, Davidson, NC (Pre-medicine, cum laude) 1981-1985 M.D. Pennsylvania State University Medical School 1993-1996 M.P.H. Yale University, Department of Epidemiology and Public Health, School of Medicine (Division of Chronic Disease Epidemiology) POSTGRADUATE TRAINING: 1985-1986 Intern, UCLA and West Los Angeles VA Medical Center 1986-1989 Psychiatry Resident, UCLA Neuropsychiatric Institute (NPI) 1988-1989 Executive Chief Resident, UCLA Department of Psychiatry and Brentwood VA 1989-1990 Addiction Psychiatry / Substance Abuse Fellowship, UCLA and Brentwood VA LICENSURE: 1987-Present California 1990-1999 Connecticut 1998-2009 New Jersey (2009 Inactive ) 2007-Present Massachusetts CERTIFICATION: 01/1994 Diplomat in Psychiatry, American Board of Psychiatry and Neurology 04/1996 Addiction Psychiatry, Added Qualifications, American Board of Psychiatry and Neurology, Re-certified April 2006 ACADEMIC APPOINTMENTS: 1990-1996 Assistant Professor, Department of Psychiatry, Yale University 1996-1998 Associate Professor, Department of Psychiatry, Yale University 1998-2001 Associate Professor, Department of Psychiatry, UMDNJ-RWJMS 2001-2004 Associate Professor with Tenure, Department of Psychiatry, UMDNJ-RWJMS 2002-2004 Associate Professor in Health Systems and Policy Division, UMDNJ School of Public Health 1998-2007 Visiting Professor, Rutgers University Center for Alcohol Studies

1999-2006 Visiting Professor, Princeton Theological Seminary 2004-2007 Professor with Tenure Department of Psychiatry, UMDNJ-RWJMS 2004-2007 Professor in the Health Systems and Policy Division, UMDNJ School of Public Health 2006-2007 Visiting Professor/Adjunct Faculty, Temple University Graduate School 2007-Present Professor with Tenure, Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA 2012-Present Graduate School of Biomedical Sciences (GSBS), University of Massachusetts Medical School. Faculty member affiliated with: Program of Clinical & Population Health Research and Program of Neuroscience HOSPITAL APPOINTMENTS: 1990-1998 Connecticut Mental Health Center, New Haven, CT Medical Director, Substance Abuse Treatment Unit Outpatient Services, 1990-93 Director, Dual Diagnosis Treatment and Research Program, 1993-98 1990-1998 Hospital of St. Raphael, New Haven, CT Medical Director, Chemical Dependence Evening Partial Hospital and Outpatient Program 1990-1992 Gaylord Hospital, Wallingford, CT Psychiatric Consultant, Substance Abuse Inpatient and Partial Hospital Programs 1992-1997 St. Mary s Hospital, Waterbury, CT Psychiatric Consultant, Behavioral Health Center 1997-1998 Waterbury Hospital, Waterbury, CT Psychiatric Consultant, Addiction Treatment Center, 1998-2007 University Behavioral Health Care, Piscataway, NJ Director, Addiction Services, 1998-2000 Director, Addiction Psychiatry PGY-V Residency Program, 1998-2006 1998-2007 Robert Wood Johnson University Hospital, New Brunswick, NJ Psychiatric Consultant 2007-present UMass Memorial Medical Center / UMass Memorial Health Care, Worcester, MA Chair, Department of Psychiatry 2007-present President, UMass Memorial Behavioral Health Services (UMMBHS) 2007-present Director, UMass Center of Excellence (COE) in Addictions (UMMHC / UMass Medical School) 2009-present Chief, UMass Memorial Medical Center Mental Health Service Line (Group Practice & Hospital) PROFESSIONAL ORGANIZATIONS (and related committee work): 1982 - present American Medical Association (AMA) 1982-1984 Delegate/Representative to AMA Conventions 1983 Co-Chair, Committee on Representation on the State Level 1984 - present American Psychiatric Association (APA) 1987-1990 Committee of Graduate Education 1987-1990 Committee of Residents and Fellows, Area VI Representative 1994-2000 Practice Guidelines Work Group on Nicotine Dependence (Work Group now incorporated into Substance Use Disorders) 1998-2000 Task Force on Nicotine Dependence; Chair, 1999-2000 1999 Drug Abuse Research Scholars Program Technical Assistance Faculty Douglas M. Ziedonis, MD, MPH 2

1999-2006 Council on Addictions; Chair, Addressing Tobacco in Psychiatric Populations Work Group 2002-2006 Practice Guidelines Work Group on Substance Used Disorders 2003-2006 Committee on Training and Education in Addiction Psychiatry 1988 - present American Academy of Addiction Psychiatry (AAAP) 1989 Co-Chair, Members-in-Training Committee 1990-1993 Board of Directors 1990-1992 Program Committee 1990-1994 Chair, Public Information Committee 1998-2000 Board of Directors 1998-2000 Co-Chair, Public Policy and Public Information Section 1999-2002 Chair, Public Information Committee 1988 - present American Society of Addiction Medicine (ASAM) 1991-2005 Family and Generations Issues Committee 1997-2001 Workgroup on Co-occurring Mental and Substance Use Disorders (Dual Diagnosis): Coalition for National Clinical Criteria 2007- Present Massachusetts Psychiatric Society 1994-2008 Group for the Advancement of Psychiatry 1994-2008 Committee on Alcoholism and Addictions 1987-2007 American Association of Directors of Psychiatric Residency Training (AADPRT), 1987-1990 Executive Committee 1988 Critical Incidence Task Force 1988-1998 Association for Medical Education and Research in Substance Abuse (AMERSA), 1988-1993 Membership Committee 1988-1993 Fellowship Training Committee 1989-1996 Program Committee, Chair 1993-1994; Co-Chair 1991-1993 1993-1995 Member at Large, Executive Committee 1996-2004 Society for Research on Nicotine and Tobacco 1998-2000 Public Policy Committee 1999-2007 New Jersey Psychiatric Society 1990-1999 Connecticut Psychiatric Society 1985-1990 Southern California Psychiatric Society 1987-1989 Government Affairs Committee 1988 Alcohol and Substance Abuse Committee 1986-1989 Psychiatric Residents Committee 1982-1985 Pennsylvania Medical Society 1982-1985 Medical Student Section Governing Council Chair 83-84, Secretary 1982-83 1983-1984 Council on Medical Practice Douglas M. Ziedonis, MD, MPH 3

1984-1985 Chair, Medical Student Well-Being Committee 1984-1985 Committee on the Impaired Physician HONORS AND AWARDS: 1982-1984 National Institutes of Health National Research Service Award 1984 Pennsylvania State University Medical School Alpha Omega Alpha (AOA) 1985 American Heart Association, Stroke Council Medical Student Scholarship Award to Study Cerebrovascular Disease 1985 Pennsylvania State University Medical School Roche Clinical/Research Psychiatry Award 1987-90 American Psychiatric Association Committee of Residents and Fellows 1992 National Institute of Mental Health's (NIMH) New Clinical Drug Evaluation Unit (NCDEU) New Investigator Award 1993 College on Problems of Drug Dependence (CPDD) Fellowship Award 1993-1998 National Institute on Drug Abuse Scientist Development Award for Clinicians (SDAC) 1994 Congress on International Neuropsychopharmacology (CINP) Rafaelsen Award 1994 Group for the Advancement of Psychiatry (GAP) Alcoholism and Addictions Committee 1994 American Psychiatric Association Practice Guidelines Work Group on Nicotine Dependence 1995 Governor's Blue Ribbon Commission on Addiction Services Co-Chair 1997 Association for Clinical Psychosocial Research Fellow 1998 Best Doctors in America 1999 American Psychiatric Association Task Force on Nicotine Dependence, Chair 1999 American Psychiatric Association Council on Addictions 2000 New Jersey Department of Health Task Force on Addictions 2001-2005 Robert Wood Johnson Foundation/RAND Advisor, Co-Occurring Disorder Project 2002 Substance Abuse and Mental Health Service Agency (SAMHSA) Advisor 2002 America s Top Psychiatrists 2002 President Bush s New Freedom Commission on Mental Health Advisor, Co-Occurring Disorders 2002 American Psychiatric Association; Substance Abuse Treatment Guidelines Advisor, Co-Occurring Disorders 2002-2012 Best Doctors in America 2003 SAMHSA Co-Occurring Disorder Treatment Improvement Protocol Panel Work Group Leader 2004 SAMHSA Co-Occurring Disorders Center for Excellence Senior Fellow 2005 American Psychiatric Association Senior Mentor APA Research Colloquium for Junior Investigators 2006 Best Doctors 2006: New York Area 2006 UMDNJ Norman H. Edelman Clinical Science Mentoring Award 2006-2010 National Institute of Mental Health (NIMH) Mental Health Services Research in Mental Health Specialty Settings Review Committee (SRSP) 2007- Steering Committee, Center for Health Quality, Outcomes and Economic Research, Bedford VA Hospital, Bedford MA 2007 President Bush s Cancer Panel 2007-2009 Institute of Medicine (IOM) Committee on Gulf War and Health: Smoking Cessation in Military and Veteran Populations, Institute of Medicine of the National Academies 2007- Establishment of the Doug Ziedonis Mentoring Award, UMass Department of Psychiatry, University of Massachusetts Medical School/UMass Memorial Medical Center Douglas M. Ziedonis, MD, MPH 4

2009 American Psychiatric Association Senior Mentor APA Research Colloquium for Junior Investigators 2009 - Special Commission on Oxycontin and Heroin (Governor Deval Patrick, Massachusetts) 2010 - Distinguished Fellow of the American Psychiatric Association 2010 American Psychiatric Association Senior Mentor APA Research Colloquium for Junior Investigators 2011 Member, Board of Directors, National Network of Depression Centers 2011 Women s Faculty Award for Outstanding Mentoring to Women Faculty, UMMS 2013-2014 Council of Deans Fellow, Association of American Medical Colleges EDITORIAL POSITIONS: 1982-1984 Pennsylvania Medical Society Insider (Co-Editor) 1987-1990 American Psychiatric Association s Psychiatric Residents Newsletter (Co-Editor) 1987-1991 The Jefferson Journal of Psychiatry (Editorial Board) 2005-2007 Journal of Substance Abuse Treatment (Editorial Board) 2008-2009 Neuropsychiatry Reviews (Editorial Board) 1992-2012 The American Journal of Drug and Alcohol Abuse (Editorial Board) 2004-Present Journal of Groups in Addiction and Recovery (Editorial Board) 2007-Present Journal of Dual Diagnosis (Editorial Board) 2011-2012 Journal of Dual Diagnosis (Editor, Special Edition 2012) 2011- Present The Scientific World Journal (Editorial Board) JOURNAL REVIEWER: 1988-Present 1990-Present 1990-Present 1993-Present 1993-Present 1995-Present 1996-Present 1997-Present 1998-Present 1998-Present 1998-Present 2000-Present 2000-Present 2000-Present 2006-Present 2009-Present 2011-Present 2011-Present Archives of General Psychiatry Drug and Alcohol Dependence The American Journal of Drug and Alcohol Abuse The American Journal on Addictions Journal of Clinical Epidemiology Schizophrenia Bulletin Schizophrenia Research Biological Psychiatry Nicotine and Tobacco Research American Journal of Geriatric Psychiatry Neuropsychopharmacology Journal of Psychotherapy Practice and Research Health Psychology Journal of Substance Abuse Treatment Administration and Policy in Mental Health and Mental Health Services Research Journal of Family, Systems and Health Human Genetics Social Psychiatry and Psychiatric Epidemiology Journal NATIONAL GRANT REVIEW PANELS, STUDY SECTIONS, COMMITTEES: 1993 Peer Reviewer, Substance Abuse and Mental Health Services Administration s Center for Substance Abuse Treatment. Treatment Improvement Protocol: Screening, Assessment, and Douglas M. Ziedonis, MD, MPH 5

Treatment Planning for Patients with Co-Existing Mental Illness and Alcohol and Other Drug (AOD) Abuse 1993 Technical Review Committee, National Institute of Drug Abuse (NIDA) Contracts Review Branch 1994 Group Consultant Reviewer, NIDA Epidemiology and Prevention Review 1994 NIDA Concepts Review Meeting "Study of Psychiatric Co-Morbidity" 1997-1999 Ad Hoc Reviewer, National Institute of Drug Abuse, Clinical Treatment Research NIDA-E Committee 1997-1999 Reviewer, National Institute of Drug Abuse Special Emphasis Panel: Co-Occurring Disorder Treatment Research 1999 Reviewer, National Institute of Drug Abuse and National Cancer Institute, Special Review Committee; Meeting: Transdisciplinary Tobacco Use Research Centers 1999 Reviewer, National Institute of Drug Abuse, Behavioral Therapy Development and Behavioral Science Special Review Committee 2000 Peer Reviewer, US Department of Health and Human Services Public Health Service: Clinical Practice Guideline: Treating Tobacco Use and Dependence Project 2000-2001 Reviewer, National Institute of Mental Health (NIMH) Special Emphasis Panel: Interventions ZMH1 ITV-D (01) 2001-2002 Work Group and Co-author, Center for Substance Abuse Treatment s Co-Occurring Disorder Treatment Improvement Protocol (TIP) 2001-Present Advisor, Robert Wood Johnson Foundation / RAND Institute, Co-Occurring Disorder 2002 National Institute Health (NIDA, NIMH, NCI) Nicotine Dependence and Medication Development Experts Panel 2002-2003 Advisor, President Bush s New Freedom Commission on Mental Health, Co- Occurring Disorders Subcommittee. Co-Author of Co-Occurring Mental Illness and Addiction Issue Paper. (Minkov, K. and Ziedonis, D.M.) 2002-2004 Consultant and Co-organizer, Robert Wood Johnson Foundation, National Initiative Advisory Panel: Addressing Tobacco amongst Individuals with Mental Illness or Addiction. 2002-2004 Work Group Leader, SAMHSA Co-Occurring Disorder Treatment Improvement Protocol (TIPS #42) Panel 2002-2004 Expert Consultant, Substance Abuse and Mental Health Service Agency (SAMHSA), Co- Occurring Mental Illness and Addiction Report To Congress 2002-2004 Advisor, Substance Abuse and Mental Health Service Agency (SAMHSA), Co- Occurring Disorders Initiative National Registry of Effective Programs 2004-2009 Senior Fellow, SAMHSA Co-Occurring Disorders Center for Excellence (COCE) 2005 NIMH Tobacco Use and Cessation in Psychiatric Disorders Workgroup 2005 SAMHSA Policy Academy 2006 Technical Report Consultant, National Association of State Mental Health Program Directors (NASMHPD) Smoking Policy and Treatment at State Operated Psychiatric Hospitals 2006 NIH (NIDA, NIAAA, NIMH) Methodology of Conducting Pharmacologic Clinical Trials in Patients with Alcohol/Drug Dependence, and Psychiatric Co-morbidity Workgroup 2006 Reviewer, National Institute on Drug Abuse. NIDA-K: The Training and Career Development Review Committee and Special Emphasis Panels (SEPs) 2006 Robert Wood Johnson Foundation, Smoking Cessation Leadership Center 2006-2010 Reviewer, National Institute of Mental Health NIMH Mental Health Services in MH Specialty Settings Review Committee (SRSP) 2006 Expert Advisory Group, American Legacy Foundation Bringing Everyone Along: Reaching Smokers with Mental Health and Substance Abuse Disorders Project Douglas M. Ziedonis, MD, MPH 6

2007 Content Review Expert, National Development and Research Institutes, New York initiative to integrate tobacco use interventions into substance abuse treatment programs. 2007 Advisor, President s Cancer Panel 2008-2009 Institute of Medicine (IOM) Committee on Gulf War and Health: Smoking Cessation in Military and Veteran Populations, Institute of Medicine of the National Academies 2011 SAMHSA Pharmacotherapy Expert Consensus Panel on Pharmacological Treatment of Co-Occurring Disorders, Westat Corporate Headquarters, Rockville, MD 2011 Special Emphasis Panel, June 30 th. Consultant/ Telereviewer. RO1/R34 Review /ZDA1 GXM-A (05) NIDA/NIH UNIVERSITY & HEALTH CARE SYSTEM COMMITTEES: University of Massachusetts Medical School (UMMS): 2007- Executive Council Vice Chair 2011-2013 Chair 2013-2007- Clinical Research Advisory Committee 2007- National Children s Study-UMass Research Liaison Committee 2007- Compensation Committee 2007 UMass Academic Health Center Strategic Planning Task Force 2007 Co-Chair, Faculty and Leadership Development Committee 2007 Research Workgroup of the UMass Academic Health Center Strategic Planning Effort 2007-2009 Clinical and Translational Sciences Award Initiative Advisory Committee 2007-2009 Clinical and Translational Sciences Award Initiative Aims and Themes Writing Group 2007-2009 Clinical and Translational Sciences Award Initiative Bench to Bedside Writing Team 2007-2009 Clinical and Translational Sciences Award Initiative T2 Core Writing Group 2008- Chairs Strategic Council 2008-2011 New Campus Facility Executive Team 2008-2011 Albert Sherman Center Executive Committee 2008 Leadership Council Subcommittee on Research Core Facilities 2008-2012 Member, Learner-centered Integrated Curriculum (LInC) Steering Committee 2009 Faculty Forward (internal leadership for AAMC initiative) Task Force 2009 Office of Federal Contracts and Compliance (OFCCP) Recruitment Task Force 2009-2012 Steering Committee Member, Center for Health Quality, Outcomes and Economic Research, Bedford VA Hospital 2010 - UMass Center for Clinical & Translational Science 2010 UMMS Distinguished Service Award Committee 2010 UMMS Postdoctoral Recruitment Process Committee 2010- UMMS Faculty Recruitment Process Committee 2010 Co-Chair UMMS/UMMHC Shared Identity Steering Committee 2010 Faculty Recruitment Process Committee 2010 Post-Doc Recruitment Process workgroup 2010 Empowering Research Faculty Task Force 2011 Expedited Process, Training Process, and Outreach and Advertising workgroup (subcommittee of Faculty Recruitment Process Committee) 2011 LCME Subcommittee on Student Health Services, Financial Aid, and Academic Counseling 2011 Empowering Research Faculty Committee Douglas M. Ziedonis, MD, MPH 7

2011 Chancellor's Award for Distinguished Service Committee 2011- Advisor, UMMS Center for Integrated Primary Care 2011- Transplant Quality Council 2011 Deep Sequencing Core and Bioinformatics Core Planning Group 2011- Neuroscience Steering Committee 2012 Tenure Committee 2012 Chancellor s Medal for Distinguished Service Selection Committee 2012 Commonwealth Care Alliance Workgroup 2012- Co Chair, 2012 CTSA Clinical Research Scholar (K12) Award Committee 2013- Community Health Improvement Plan (CHIP) Committee 2013- Stewardship Group for Joint Campus Strategic Planning UMass Memorial Health Care (UMMHC) 2006- Leadership Council 2006- Clinical Performance Council 2006- Group Practice Advisory Committee 2006- President and Chairman of the Board, UMass Memorial Behavioral Health System 2007- Member, Advisory Board, UMMHC Primary Care Strategy Integration 2007- Primary Care Integration System Advisory Group 2007- Resource Group Large Capital Projects Committee 2007- UMass Memorial Strategic Planning Task Force 2009 Medical Group Contingency Steering Committee 2010 Behavioral Health Planning Committee 2011 Total Health Management (Wellness) 2011- Co-Chair, Behavioral Health Strategic Plan Implementation Stakeholders 2011- Member, UMass Memorial Cancer Center of Excellence 2011- Member, Center for Advance Primary Care Advisory Committee 2012-2013 Member, McKinsey Operations Transformation Engagement Group 2012-2013 Co-Chair, Primary Care Executive Committee UMMS/UMMHC SEARCH COMMITTEES: 2007-2008 Chair, Chair of Neurology Search Committee 2007-2008 Quantitative Health Sciences Chair Search Committee 2008 Vice Provost for Faculty Affairs (VPFA) Search Committee 2008- Cancer Clinical Center of Excellence Director Search Committee 2008-2009 Bedford VA Mental Health Service Line Manager Search Committee 2009 Institutional Leader of Bioethics Search Committee 2009 Director, Diabetes Center of Excellence Search Committee 2009 Associate Vice Chancellor for Diversity and Equal Opportunity Search Committee 2009- Director, University of Massachusetts Institute for Health Policy (IHP) Search Committee 2009-2010 Quantitative Health Sciences Chair Search Committee 2009-2010 Inaugural Director of the University of Massachusetts Institute for Health Policy Search Committee 2010 Radiology Chair Search Committee 2011 Chief Medical Officer Search Committee 2011 Bedford VA Mental Health Service Line Manager Search Committee 2011 Co-Chair, Chief Information Officer Search Committee Douglas M. Ziedonis, MD, MPH 8

2012- Commonwealth Medicine Chief Academic Enhancement Officer Search Committee 2012- Urology Search Committee 2012-2013 President Search Committee COMMITTEES: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (UMDNJ) & UNIVERSITY BEHAVIORAL HEALTH CARE (UBHC): UMDNJ - University Behavioral HealthCare 1999-2006 Executive Committee 1998-2006 Chair (1998-2000) Addiction Services Leadership Committee 1998-2006 Medical Staff Committee 1998-2000 Chair, Addiction and Dual Diagnosis Training Committee Cancer Institute of New Jersey (CINJ) 2004-2006 Population Science Leadership Group 2004-2006 Director, Addiction Research Program at the CINJ 2004-2006 Primary Mentor, CINJ Faculty Development Award (Drs. Foulds and Steinberg) ROBERT WOOD JOHNSON MEDICAL SCHOOL / UMDNJ COMMITTEES Robert Wood Johnson Medical School: 2000-2006 Chair, Curriculum Committee s Subcommittee on Substance Abuse 2000-2006 Medical Student Well-being/Impairment Committee 2002-2006 Faculty Well-being/Impairment Committee 2002-2006 House Staff Well-being/Impairment Committee Department of Psychiatry 1998-2006 Chairman s Advisory Committee 1998-2006 Chairman s Executive Committee 1998-2006 Chair, Addiction Psychiatry Fellowship and Post-Doctoral Student Training Committee 1999-2006 Chair, Addiction Psychiatry Residency Education Subcommittee 1999-2006 Interdisciplinary Training Committee Douglas M. Ziedonis, MD, MPH 9

BUILDING CONSTRUCTION PLANNING / IMPLEMENTATION EXPERIENCE Yale University Addiction Division Building at Connecticut Mental Health Center Dual Diagnosis Unit 1 st floor Buildouts for: APT Foundation MMP and clinical program Robert Wood Johnson Medical School The Mercer County Addiction Science Center building - Trenton Tobacco Center Buildouts New Brunswick Addiction Psychiatry and Tobacco Department Program buildouts New Brunswick. University of Massachusetts Medical School (UMMS) / UMass Memorial Healthcare (UMMHC) New Buildings: UMMS Albert Sherman Center building (2012) UMMS ACCESS Building Clinical Research (2011) Worcester Recovery Center and Hospital (2012; formerly Worcester State Hospital) - MA Department of Mental Health Building Renovations: UMMHC Psychiatric Treatment & Recovery Center Unit relocation to Worcester (2013) Worcester State Hospital redesign of two floors: Center for Mental Health Services & Adolescent Units UMMHC Psychiatric Outpatient Department New Facility - 2013 UMMHC Community HealthLink upgrades and new building expansion construction UMMS Biotech 1 Career Development & Research Office, Offices for Addiction Research, Child Psychiatry Research, Psychosis Research Units VETERANS AFFAIRS (VA) HEALTH CARE SYSTEM VA Brentwood / Wadsworth - UCLA (1985-1990) Director, Dual Diagnosis Treatment and Research Program, West Los Angeles UCLA Department of Psychiatry (1989-1990) with R. Liberman, S. Marder, A. Shaner, L. Roberts, and T. Eckman Chief Resident - UCLA Psychiatry Department VA West Haven CT / Yale University (1990-1998) Faculty Yale University Addiction Psychiatry Residency Program Research Collaborator, MIREC on Co-Occurring Disorders National Activities: Co-Occurring Disorders / Smoking Cessation (1998-2006) Cooperative Studies Review Committee Reviewer for Multi-Center VA Cooperative studies programs in smoking cessation. VA at the Vanguard: National Committee identifying needs and strategies to address smoking amongst veterans Data Use Agreement Project with VA Central Office to use the EPR/SHEP Datasets. Coinvestigator and technical advisor on a joint project between VA New Jersey and VA Central office to examine smoking Patterns among the mentally ill. The collaborator in Douglas M. Ziedonis, MD, MPH 10

VA Central Office is Thomas Craig (Chief Medical Officer/Office of Quality Improvement). VA Dual Diagnosis Task Force Committee Member VA New Jersey (1998-2007). Senior Consultant - Dual Diagnosis Program and Services Addiction Psychiatry Residency Program Research Psychiatrist: Addiction, Dual Diagnosis and Tobacco Dependence. Co-investigator on several grants testing out a care coordination model called TLC with Veterans that involve an integration of case management, peer support and Dual Recovery, including Dual Recovery Therapy initiatives throughout VISN 3. The TLC model has been selected as a "Promising Practice" from the VA Mental Health Strategic Health Care Group and has been disseminated to other VA's nationally. Health and Human Services-Center for Substance Abuse Treatment # TI16576, Award Amount $1,968,071 Title: Maintaining Independence and Sobriety through Systems Integration, Outreach and networking: The MISSION Program. PI: D. Smelson, Co-PI: A. Kline, Co-I: D. Ziedonis, B. Sussner, M. Losonczy. October 2004-September 2009 (DZ active 2004 2007) VA HSRandD Merit Review Grant # IIR-020-145, Award Amount $686,909. Title: A Brief Community Linkage Intervention for Dually Diagnosed individuals. PI: D. Smelson, Co-I's: M. Losonczy, A. Kline, B. Sussner, D. Ziedonis, F. Blow. February 2005 - February 2009. (DZ active in 2005 and 2006) Veterans Administration Millennium Funding $414,000. Transitional Treatment Interventions-Time-limited Case Management. PI: David Smelson, Co-PI: M. Losonczy, D. Ziedonis, May 1999-2003 Veterans Administration Award Amount $864,434. May 2005-May 2008. Time-Limited Case management for Chemically Addicted Mentally Ill. PI: D. Smelson, Co-PI: A. Kline, CO-I's: B. Sussner, M. Losonczy, D. Ziedonis (DZ active in 2005 and 2006). VA MASSACHUSETTS (2007 present) VA Boston Worcester Community Based Outpatient Clinic (2007 - ) Established new academic partnership for UMass Department of Psychiatry VA Bedford (2007 - ) Advisor, Center for Health Quality, Outcomes and Economic Research National HRS&D Center 2007-2013 Leader in academic partnership development for the UMass Medical School with the Bedford VA Health Care System VA Northampton (2008 - ) Leader in academic partnership development for the UMass Medical School with the Northampton VA Health Care System Douglas M. Ziedonis, MD, MPH 11

COMMUNITY 1990-1998 South-Central Connecticut Mental Health Network Dual Diagnosis Committee, Chair, 1990-1998 Annual Dual Diagnosis Conference Committee, Chair, 1990-1998 Clinical Services Committee, 1994-1998 1992-1998 Connecticut Department of Mental Health and Addiction Services (DMHAS) Dual Diagnosis Task Force, Co-Chair Systems Development Work Group, 1996 Planning Group Committee on Mental Illness / Substance Abuse, Budget Option Subcommittee, Co-Chair, 1992-1994 Diagnosis Related Work Group: Mental Illness/Substance Abuse. Treatment Outcome Subcommittee, Co-Chair, 1993-1994 1995-1996 Connecticut Governor's Blue Ribbon Commission on Addiction Services, Co-Chair 1996-1998 Connecticut Alcohol and Drug Policy Council (Outcomes Monitoring, Youth and Family, and Treatment Committees) 1997-2000 Ethics and Morals Study Commission, Consultant Latvian Evangelical Lutheran Church in America 1998-2001 New Jersey State MICA Task Force and County MICA Task Forces (Warren County, Ocean County, Union County, and Middlesex County) 1999-2001 New Jersey Department of Mental Health s MICA Critical Pathways Workgroup 1999-2003 State of New Jersey, Governor s Council on Addictions, Leadership Forum Group 2000 New Jersey Department of Health Task Force on Addictions 2002-2004 New Jersey Department of Health and Human Services, Division of Addiction Services: Advisory Committee on Quality Standards for Addiction Treatment Chair, 2002-2004 2002-2005 New Jersey Department of Mental Health Task Force on Co-Occurring Disorders 2007-present Board of Directors, Community HealthLink, Inc. 2007-present Chair, Board of Directors, UMass Behavioral Health System (UMBHS) 2007-present Central Massachusetts Addiction Consortium, Founding Chair 2008 Expert reviewer of the manual for Behavioral Treatment of Smoking Cessation in SMI (BTSCS) 2008-2010 Advisory Board member, Center for Behavioral Health Services Criminal Justice Research, Rutgers University 2008-09 External Reviewer: St. Luke s Roosevelt Hospital Center, NYC, Department of Psychiatry 5 Year Review 2009 Chair, Review Team, University of Connecticut, Hartford, CT, Department of Psychiatry, 5 Year Review 2011 Worcester Anti-Tobacco Task Force, The Worcester Division of Public Health and the Central MA Tobacco-Free Community Partnership, UMass Department of Psychiatry 2011-present Member, Skyland Trail National Advisory Board 2012-present Member, Advisory Board for the Hector E. Reyes House in Worcester, Massachusetts FACULTY ADVISOR TO CANDIDATES FOR POSTGRADUATE DEGREE: 1995-1997 Connie Nickou (PsyD) Yale University 2000-2001 Elizabeth Pratt (PhD thesis) Rutgers University 2000-2003 Marc Steinberg (PhD thesis) University of Miami 2004-2007 Kathy Murphy (PhD thesis) Temple University Douglas M. Ziedonis, MD, MPH 12

June 11, 2010 Colonie Marie Kelli Gray (PhD) Florida International U. NIMH Conference, New Brunswick NJ 2012 Katherine Riva SPONSORSHIP OF POSTDOCTORAL FELLOWS: 1998-2007 Robert Wood Johnson Medical School Addiction Research Post-Doctorate Fellows Beryl Johnson, PsyD 1998-1999 Ilana Pinsky, PhD 1999-2000 Marc Steinberg, PhD 2000-2003 Erin O Hea, PhD 2003-2004 Thomas Hildebrandt, PhD 2004-2006 1990-2007 Addiction Psychiatry PGY-V Residents / Fellows Yale University Michael Thomas, MD 1990-1991 Ismene Petrakis, MD 1991-1992 David Sikowitz, MD 1993-1994 Amal Tanagho, MD 1994-1995 Surita Rao, MD 1995-1996 Tony George, MD 1996-1997 Steven Wyatt, DO 1997-1998 UMDNJ Robert Wood Johnson Medical School Jill Williams, MD 1998-1999 Abir Marcus, MD 2000-2001 Jeff Berman, MD 2000-2001 Michael Centrella, MD 2001-2002 Alina Vrincanau, MD 2001-2002 Steven Maslany, DO, PhD 2003-2004 Michael Dallolio, MD 2003-2004 Miguel Flores, MD 2003-2004 Carla Hardy, MD 2005-2006 John Cooke, MD 2006-2007 Elena Volfson-Doubova, MD 2006-2007 Allen Masry, MD 2006-2007 2007-Present UMass Addiction Psychiatry Training Program Leader - Faculty Development Group Leader Addiction Psychiatry Residency Program Development Work Group 2010 NIMH Minority Program Mentor Critical Research Issues in Latino Mental Health Conference & Mentoring Program, New Brunswick NJ - Mentee: Calonie M.K. Gray, PhD Douglas M. Ziedonis, MD, MPH 13

TEACHING RESPONSIBILITIES: University of Massachusetts Medical School: 2007-Present Chair s Case Conference with Residents & Service Lines Biological Psychiatry Seminar for PGYIII and IV Residents Didactic Seminar Series for Psychiatry Residents Mind, Brain, Behavior II Course for Medical Students Addiction Psychiatry Seminar for Residents / Fellows Psychology Internship Lecture of Co-occurring Disorders (Addiction and Mental Illness) Leadership and Management Seminar for Residents Research Career Writing Group(K-Award Group) mentorship Tobacco Addiction Rounds (TAR) for Medical Students on C/L rotation Robert Wood Johnson Medical School: Addiction Psychiatry PGY-V Residency Program, Director, 1998-2006 ACGME approved in December 1999 Substance Abuse Seminar for Child and Adolescent Psychiatry Fellows, 1999-2006 Clinical Supervisor for Medical Students, Psychiatric Residents, and Addiction Psychiatry Fellows within the University Behavioral HealthCare System, 1998-2006 Third Year Medical Students Psychiatry Clerkship Addiction Lectures, 1998-2006 Substance Abuse Seminar for Second Year Psychiatry Residents, 1998-2006 Substance Abuse Seminar for Fourth Year Psychiatry Residents, 1998-2006 Second Year Medical Students / Behavioral Science and Psychiatry Course, 1999-2004 Second Year Residents Psychopharmacology Seminar, 1999-2006 ASAP Elective for MSII Medical Students, Faculty Sponsor, 1999-2001 First Year Medical Students Case-Based Learning, 1998-2003 Princeton Theological Seminary Courses: Faith and Addiction, 1999-2000 Spirituality and Health, 2000-2005 Yale University: Psychiatric Emergency Room Seminar Series for Second Year Psychiatry Residents, Faculty Lecturer, 1990-1993 Substance Abuse Treatment Unit (SATU) Seminar Series for Medical Students and Residents, Coordinator and Faculty, 1990-1993 Substance Abuse Seminar for all Third Year Medical Students (during the core Psychiatry Clerkship), Seminar Coordinator and Faculty, 1990-1998 Psychopharmacology Seminar for Second Year Psychiatry Residents, Faculty Lecturer, 1990-1998 Yale's Comprehensive National Boards Review of Psychiatry and Neurology Course, Faculty Lecturer, 1992-1995 Psychiatric Epidemiology Seminar, School of Public Health, Faculty Lecturer, 1994 to 1998 Introduction to Substance Abuse Seminar - 10 week seminar for PGY III residents, Coordinator and Faculty, 1994-1998 Seminar on Family Study Methodology, Genetic Epidemiology Research Unit, Faculty, 1994-1998 Substance Abuse / Dual Diagnosis Seminar for CMHC Outpatient Division (weekly seminar, September through April), Seminar Coordinator and faculty, 1994-1998 Clinical Supervisor for Medical Students, Psychiatric Residents, and Substance Abuse Fellows at the Connecticut Mental Health Center, 1990-1998 Douglas M. Ziedonis, MD, MPH 14

University of California Los Angeles (UCLA): Psychiatry Interviewing Course for First Year Medical Students, Instructor - 1987 Psychiatry Third Year Medical Student Clerkship Core, Instructor, "Affective Disorders" and "Biopsychosocial Model", 1988-1989 Substance Abuse Seminar for First and Second Year Medical Students, Co-organizer, 1988-1989 Assessment and Interview Course for Second Year Psych Residents, Coordinator, 1989 Clinical Fundamentals Course for Second Year Medical Students, Instructor, 1989 Substance Abuse Seminar Course for Second Year Psychiatry Residents, Coordinator, 1989 Substance Abuse Seminar: Issues and Innovations in Treatment, Prevention, Research, and Public Policy; Instructor, 1989 Pennsylvania State University: Physical Diagnosis Course for Medical Students, Instructor, 1984 Substance Abuse Seminar for Medical Students, Coordinator, 1984-1985 INVITED PRESENTATIONS: NATIONAL/INTERNATIONAL MEETINGS Representative Sample of Grand Rounds Presentations: Representative Sample of Presentations: Present approximately 6 Grand Rounds per year at Universities nationally on topics of Co-Occurring Mental Illness and Addiction, including Tobacco and Serious Mental Illness, or other Addiction Psychiatry related topics. In the past about ten years have given Grand Rounds or related lecture at Harvard-McLean Hospital, Yale University, Boston University, University of Massachusetts, University of Pennsylvania, Columbia University, NYU, UCLA, UCSF, University of Washington, University of North Carolina, Penn State, SUNY, University of Maryland, University of Hawaii, University of New Mexico, University of Louisville KY, University of Michigan, University of Chicago- Northwestern, Vanderbilt University, Medical College of Virginia, University of Missouri, Temple University, RWJMS-Camden, RWJMS-Piscataway, and the Menninger s Foundation. Present at approximately 6-12 meetings per year. Here is a representative sample of recent presentations: Annually since 1991 Invited Lecturer - American Psychiatric Association Annual Meeting Recent Lecture Topics in the past three years: Schizophrenia and Tobacco, NIAAA Symposium (Motivational Enhancement Strategies to Address Substance Use Disorders); NIDA Symposium (Integrating Tobacco Dependence Treatment into Mental Health Treatment); Why Psychiatrists and Mental Health Professionals Should Take a Lead in Tobacco Dependence Treatment; Recovery-Oriented Psychosocial Treatments; Treatment of Co-Occurring Addiction and Schizophrenia; Developing a career in addiction research psychiatry; Treatment of Nicotine Dependence in Individuals with Schizophrenia. Douglas M. Ziedonis, MD, MPH 15

May 2005 Feb 28-Mar 1, 2006 March 2006 April 2006 April 28, 2006 September, 2006 October 2006 February 12, 2007 Veterans Affairs Health Care System: National Conference on Tobacco Use and Dependence. Keynote Presentation: Addressing Tobacco in Addiction and Mental Health Settings. Veterans Affairs Mental Illness Research and Education Center Annual Meeting. Presentation on Integrating Dual Recovery Therapy and Medications: Recovery and Rehabilitation for Co-Occurring SMI and Addiction. Los Angeles, CA. NIAAA/NIDA/NIMH Conference: Methodology of Conducting Pharmacologic Clinical Trials in Patients with Alcohol/Drug Dependence and Psychiatric Comorbidity. Washington DC Outcome Measures. SAMHSA: Co-Occurring Disorders State Initiatives Conference. Washington DC. Presentation on Evaluation of the COSIG Initiative. National Association of State Mental Health Program Directors: Smoking Policy and Treatment in State Operated Psychiatric Facilities Summit Meeting. San Francisco, CA. Presentation on Addressing Tobacco in Mental Health State Hospitals through Organizational Change. Northwest Research and Education Institute Annual Conference on Practical Use of Psychiatric Medications. Billings, MT. Keynote Presentation: Co-Occurring Disorders: An Update Robert Wood Johnson Foundation Smoking Cessation Leadership Council Annual Meeting. Tobacco Use and Dependence amongst Psychiatric Patients. Carolinas Conference on Addiction and Recovery, Chapel Hill, NC. Lecture on Treating Nicotine Dependence and Other Substances President's Cancer Panel Meeting (Promoting Healthy Lifestyles to Reduce the Risk of Cancer). Tobacco Dependence and Psychiatric Illness. University of Mississippi, Jackson, MS February, 2007 Williams JM, Gandhi KK, Foulds, J, Steinberg MB, Lu Shou-En, Masumova F, Straun, T, Ziedonis D. No Advantage for High Dose Compared to Regular Dose Nicotine Patch on Short-term Abstinence Rates in Schizophrenia. Oral Paper Session at the 13th Annual Meeting of the Society for Research on Nicotine and Tobacco (SRNT). Austin TX. April 23, 2007 May 3-6, 2007 May 8-9, 2007 May 11, 2007 October 12, 2007 November 6, 2007 March 7, 2008 April 11, 2008 Law & Psychiatry Seminar Series. Law and Addiction Psychiatry: Untapped Opportunities. University of Massachusetts Medical School, Worcester, MA Ninth Annual Future Leaders in Psychiatry meeting. Co-Occurring Addiction and Mental Illness: Tobacco Dependence and Schizophrenia. The neurobiology and treatment of drug abuse. Emory University, Atlanta, GA NIDA Conference - The Future of Youth Tobacco Cessation Research. Tobacco use, mental illness, and adolescence: what are the relationships and impact. Rockville, MD Mind, Behavior and Brain Course for 2 nd Year Medical Students. Addressing Spirituality in Medicine. University of Massachusetts Medical School, Worcester, MA Presentation at Carrier Clinic conference - Caring Solutions for Adults with Mental Illness: Improving Mental Health Care & Outcomes. Bridgewater, NJ Family Medicine Grand Rounds. Co-Occurring Depression and Addiction. UMass Memorial Medical Center, Memorial campus, Worcester, MA Addressing Tobacco Through Organizational Change Addiction 08 Third Annual Conference, New York City, Addiction Institute of New York ASAM s 39 th Annual Medical-Scientific Conference (NIDA), Smoking Cessation in the Practice of Addiction Medicine Symposium, System Douglas M. Ziedonis, MD, MPH 16

Approaches to Address Tobacco Dependence in Addiction Medicine Toronto, Ontario April 11, 2008 Addiction Rounds, Motivation Based Treatment Model & Dual Recovery Therapy for Co-Occurring Schizophrenia and Addiction, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario April 28, 2008 15 th Annual Mayo Clinic Nicotine Dependence Conference A Focus on Mental Illness and Substance Abuse, Screening and Assessing Mental Health Disorders and Substance Abuse in a Tobacco Intervention, Rochester, Minnesota. May 24, 2008 Annual Future Leaders Meeting Co-occurring mental illness and addiction: schizophrenia and nicotine dependence, Orlando, Florida. June 13, 2008 2 nd National Conference on Dual Diagnosis Organizational Change in Psychiatric Systems for Addressing Nicotine Dependence in the Mentally Ill, Indianapolis, Indiana. June 25, 2008 Quincy Mental Health Center Special Grand Rounds Addressing Tobacco Dependence IN Psychiatry Is Part of Public Sector Psychiatry, Quincy, MA. June 29, 2008 1 st Annual Chair In Psychiatry Summit, Neurobiology and Treatment of Nicotine Dependence, Hilton Head Island, SC. September 4, 2008 Grand Rounds presentation: Spirituality and Mental Health Care: What s Our Role?, University of Massachusetts Medical School, Worcester, MA September 14, 2008 Moderator, 2008 Healthy Minds Across America event sponsored by NARSAD, University of Massachusetts Medical School, Worcester, MA November 17, 2008 Workshop Case Study Presenter: Continuing Education Program for Tobacco Treatment Specialist, SUD and Mental Health Providers. Sponsored by Center for Tobacco Treatment Research and Training, Massachusetts Dept of Public Health and UMass Medical School. Making the Case for Tobacco Treatment in SUD and MI March 3, 2009 Outpatient Addictions Treatment Academic Lecture Series, Cambridge Health Alliance/Harvard Medical School. Addressing Tobacco in Addiction Treatment Programs March 16, 2009 Author in Room call (hosted by Institute for Healthcare Improvement [IHI] in partnership with JAMA collaboration) A 51-Year Old Woman with Bipolar Disorder Who Wants to Quit Smoking, published February 4, 2009, by Dr. Steven Shoroeder in JAMA. Guest speaker with Dr. Chuck Kilo, Greenfield Health, Portland, OR. April 28, 2009 7 th Nursing Excellence Conference, Graduate School of Nursing, UMass Medical School, Inter-Professional Keynote Address: Tobacco Addiction: State of the Science and How to Integrate into Your Career September 15, 2009 Mental Health Substance Abuse of Massachusetts: Addressing Tobacco in Mental Health and Substance Abuse Corporations in Massachusetts, Natick, MA October 6, 2009 Grand Rounds, Westborough State Hospital: Spirituality and Mental Health Care: What's Our Role? October 22, 2009 National Conference of State Legislators Legislator in the Lab Program, UMMS Disparities amongst individuals with mental illness and addiction: Impact of Smoking and Obesity November 5, 2009 The Healthy Mind: Understanding and Coping with the Effect of Mood. (Lecture Series with Jean Frazier, MD). UMass Medical School/UMass Memorial, Worcester MA. April 10, 2010 Moderator, 2008 Healthy Minds Across America event sponsored by NARSAD, The Brain and Behavior Research Fund, University of Massachusetts Medical School, Worcester, MA Douglas M. Ziedonis, MD, MPH 17

April 20, 2010 April 26, 2010 May 22, 2010 August 31, 2010 November 30, 2010 December 6, 2010 December 7, 2010 March 4, 2011 May 20, 2011 June 25, 2011 September 8, 2011 September 10, 2011 September 30, 2011 October 19, 2011 December 13, 2011 February 18, 2012 March 9, 2012 March 24, 2012 April 11, 2012 April 30, 2012 October 2012 Schechuan University, Chengdu, China. Addressing Tobacco in Mental Health Settings: China and United States Experiences and Opportunities. Peking University, Beijing, China. Tobacco Addiction and Psychiatry. APA Symposium: Smoking and Psychiatric Disorders: Clues About Causal Pathways and Innovative Treatment Approaches. Integrating Tobacco Dependence Treatment Into Mental Health and Addiction Treatment, New Orleans, LA Tobacco Training, Genesis Club, Worcester, MA Introduction to ATTOC/Stress Reduction, Mindfulness, and Integrating MET Tobacco Training, Genesis Club, Worcester, MA Introduction to ATTOC/Stress Reduction, Mindfulness, and Integrating MET Train the Trainer, Bermingham Group Health Services in Sonia, CT Grand Rounds, Worcester State Hospital, Worcester MA Spirituality and Mental Health Care: What's Our Role? Motivation Based Treatment for Tobacco Addiction, Harvard Medical School Department of Continuing Education Treating the Addictions course, Boston Park Plaza, Boston, MA Innovations in Addictions: Adapting to Change Conference: Addressing Tobacco Through Organizational Change, Norwood, MA 4 th Annual Chairs Summit, Master Class for Neuroscience Professional Development, Baltimore MD, Smoking Cessation and Managing Pain in Addiction and Co-Occurring Addictions Grand Rounds, Food Addiction: Is Obesity a Brain Disorder? UMass Medical School, Department of Psychiatry, Worcester MA. Cape Cod Symposium on Addictive Disorders Plenary Session. Treating tobacco addiction in substance abuse treatment settings: Identifying benefits, challenges, and interventions that work. Grand Rounds, University of Wisconsin Department of Psychiatry, Madison WI. Tobacco Addiction: Motivation Based Treatments and Organizational Change Grand Rounds, Sheppard Pratt, Baltimore (Towson) MD Addressing Tobacco in Mental Health and Addiction Treatment Programs Webinar Panelist: Tobacco-Free: Patients, Policy, & Practicum. Massachusetts Hospital Association s Healing Inside and Out: MA Tobacco- Free Hospitals initiative Georgia s APA Chapter Winter Meeting, Atlanta, GA. Keynote Speaker, Improving Outcomes for Co-Occurring Disorders, Addiction & Mental Illness SUNY Buffalo Grand Rounds, Buffalo, NY Behavioral Therapy for Smoking Cessation. Healthy Kitchens, Healthy Lives, Napa Valley, CA (Culinary Institute of America and Harvard Medical School) Keynote Address: Overeating and Obesity through the Addictions Lens Grand Rounds, Bedford VA (Boston University CME series). Addressing Tobacco in VA Mental Health & Addiction Treatment Intensive Tobacco Treatment Training & Conference, Portland, Maine. Keynote Speaker: Addressing Tobacco in Mental Health & Addiction Settings and Motivation Based Treatment for Tobacco Addiction.. Medical Student Education in the United States. Keynote Speaker. Sichuan University, Chengdu China Douglas M. Ziedonis, MD, MPH 18

CLINICAL RESPONSIBILITIES / MANAGEMENT: (Including system development and consultation at Network, State and National levels) UMass Memorial Health Care (UMMHC) Chair Department of Psychiatry UMMHC Psychiatry Services include: Adult Mental Health Unit, Neuropsychiatric Disabilities Unit, Psychiatric Treatment Center, Consultation/Liaison Service, Ambulatory Psychiatry Service, Emergency Mental Health Service, UMass Adolescent Units, Transitions Intensive Residential Treatment Program, Worcester Communities of Care Chief Psychiatry Service Line (UMass Memorial Medical Center Hospital / Group Practice) Chief - Tobacco Addiction Consultation Service UMass Memorial Behavioral Health Services (UMMBHS) President UMMBHS Board of Directors Community Health Link Board of Directors MA Department of Mental Health UMass Public Sector Services Chair Department of Psychiatry UMass Public Sector Services provide or have provided services at: Worcester Recovery Center and Hospital, Community HealthLink, Inc., Quincy Mental Health Center, Westborough State Hospital, The Carson Center, Shattuck Hospital, Worcester State Hospital, and Tewksbury Hospital Network, State and National System Development and Consultation 2004-2010 Senior Fellow and System Consultant, SAMHSA Co-Occurring Disorder Center for Excellence 2005-2009 Grant Evaluator, Co-Occurring Disorder State Initiative 17 States Program 2007 - present Co-Founder and Director, Central Massachusetts Addiction Consortium (CMAC) University Medicine and Dentistry of New Jersey / University Behavioral HealthCare (UBHC) 1998-2006 Executive Committee (Leadership Committee for all UBHC activities) 1998-2000 Director, University Behavioral HealthCare Addiction Services 1999-2001 Consultant, State of New Jersey, Governor s Council on Addictions Addressing Tobacco Program and Systems Consultant, State of New Jersey, Addiction and Mental Health Agencies 1998-2006 Psychiatric Consultant, UBHC & Robert Wood Johnson Medical School University Medical Group 1998-2006 Director, Addiction Psychiatry Treatment and Consultation Services, 1998-2006 Co-Founder and Director, NJ Addiction Consortium 2000-2006 Director, Trenton Tobacco Dependence Treatment Program 2002-2004 Director, Robert Wood Johnson University Hospital Addiction Services, UMDNJ, School of Public Health 2000-2006 Medical Director, UMDNJ Tobacco Dependence Program Douglas M. Ziedonis, MD, MPH 19

Connecticut Mental Health Center (CMHC) / Yale University 1993-1998 Director, Dual Diagnosis Treatment and Research Program 1990-1996 Co-Director/Medical Director, Substance Abuse Outpatient Treatment Unit APT Foundation 1990-1994 Medical Director, APT Foundation's Methadone Maintenance Program Hospital of St. Raphaels, New Haven, CT 1990-1998 Co-Director and Medical Director, Chemical Dependence Evening Partial Hospital Program Gaylord Hospital Substance Abuse Inpatient and Partial Hospital Programs 1990-1992 Consultant, Wallingford, CT St. Mary s Hospital and Behavioral Health Center, Waterbury, CT 1992-1997 Psychiatric Consultant Waterbury Hospital and Addiction Treatment Center, Waterbury, CT 1997-1998 Psychiatric Consultant CT Network and State System Development and Consultation: 1996-1998 Connecticut Alcohol and Drug Policy Council 1996-1998 Co-Chair (1995-1996), Connecticut Governor's Blue Ribbon Commission on Addiction Services Connecticut Department of Mental Health and Addiction Services (DMHAS) Co-Chair, Dual Diagnosis Task Force Systems Development Work Group, 1996 Planning Group Committee on Mental Illness / Substance Abuse, Co-Chair, Budget Option Subcommittee, 1992-1994. Diagnosis Related Work Group: Mental Illness/Substance Abuse. Co-Chair, Treatment Outcome Subcommittee 1993-1994. West Los Angeles VA Medical Center Brentwood VA / UCLA 1989-1990 Director, Dual Diagnosis Treatment and Research Program Douglas M. Ziedonis, MD, MPH 20

LEADERSHIP & MANAGEMENT TRAINING: UCLA Tavistok Authority and Leadership Training 1987-1990 Yale University School of Management Leadership and Decision Making 1997-1998 Health Care Management and Leadership Tutorial Seminar 1993-1995 Center for Mindfulness, University of Massachusetts Medical School Cultivating Leadership Presence through Mindfulness Retreat, Warren Conference Center & Inn, Ashland MA, March 10-14, 2010. AAMC Philanthropy Workshop for Departmental Chairs and Clinical Faculty on Strategies, Skills Building and Best Practices in Philanthropy, February 9, 2011, Westwood CA Crucial Conversations Training for Leaders Worcester, MA September 2011 Intermountain Health Care - Introduction to Quality Improvement for Physicians - taught by Brent James Salt Lake City, NV November 3 4 th, 2011 UMMS Leadership Training Retreat: The Leader s Toolbox taught by Ralph Jacobson Worcester, MA March 2012 Institute for Healthcare Improvement (IHI), Quality Improvement for Chairs and Chiefs Boston, MA May 3 4, 2012 MetaStar, Inc., - Leadership in Cultural Transformation ThedaCare Corp., Appleton, Wisconsin May 16-17, 2013 Douglas M. Ziedonis, MD, MPH 21

RESEARCH GRANTS: Grants were based at the three institutions I have worked at: Yale University (1990-98) Robert Wood Johnson Medical School (1998-2007) University of Massachusetts Medical School (2007 - current). Grants In Review / Pending: 1. National Institutes on Drug Abuse (NIDA) /R21. (Under Review). Determining Nicotine Dependency Progression in Infrequent Emerging Adult Smokers. PI: G. DiGirolamo; Co-PI: D. Ziedonis 2. National Institutes of Health (NIH) / Imaging - Science Track Award for Research Transition (ISTART). (Under Review). Behavioral and Neural Response to Cocaine Cue- Reactivity. PI: D. Smelson; Co-PI: D. Ziedonis 3. National Institutes of Health (NIH)/ K99/R00. (Under Review). Innovative Smartphone Application for Quitting Smoking among Seriously Mentally Ill. PI: R. Vilardaga; Consultant: D. Ziedonis Current Grants: 1. National Center for Complementary and Alternative Medicine (NCCAM)/ R34 AT006963-01A. Mind and health: Developing a neural marker for mindfulness, a pathway to health. 05/01/2013-02/29/2016. PI: C. Fulwiler; Co-I: D. Ziedonis 2. Foundation for Excellence in Mental Health Care. Adapting the Open Dialogue Model in the United States: Developing and Piloting an Organizational Change Approach & Behavioral Therapy Manual. 11/01/2012-10/30/2014. $200,000. PI: D. Ziedonis 3. National Institute on Alcohol Abuse and Alcoholism (NIAAA) / Small Business Technology Transfer (STTR) with Polaris R41AA022035. Remote Brief Intervention and Referral to Treatment for Alcohol Misuse (R-BIRT). 09/25/2012-02/28/2014. PI: E. Boudreaux; Co-I: D. Ziedonis 4. Massachusetts Department of Mental Health, Research Center of Excellence for Systemic and Psychosocial Research. Department Chair: D. Ziedonis / Center Director: C. Fulwiler (UMMS) 01/01/2007-06/30/2014 ($6,300,000). 5. National Cancer Institute (NCI) 1R01CA136888-01A109. RCT for Smoking Cessation in 10 Medical Schools. 07/06/2009-05/31/2014. PI: J. Ockene; Co-I: D. Ziedonis 6. UMass Medical School Global Initiative. Addressing Tobacco Through Organizational Change in China. Ziedonis (PI) 09/01/2009-8/28/2013, $50,000 Douglas M. Ziedonis, MD, MPH 22

7. National Institute of Drug Abuse (NIDA) 5R01DA027138-02. Memantine-enhanced Buprenorphine Treatment for Opioid-Dependent Young Adults. 07/01/2009-06/31/2012. PI: G. Gonzalez; Co-I: D. Ziedonis 8. Connecticut Department of Public Health. Addressing Tobacco Through Organizational Change Intervention and Evaluation. 12/01/2009-04/30/2013. $225,000. UMass PI: Ziedonis (component of overall CT DPH Tobacco Dependence Program in Behavioral Health Programs $2.1M). PI: CommuniCare J.Dauer ; UMass PI: Ziedonis (Co-I overall) 9. NCRR (KL 2RR031981-01) UMass CTSA / University of Massachusetts Center for Clinical Translational Science-Education 07/01/2010-3/31/2015. Luzuriaga PI; Ziedonis Co-I / Co- Leader: K12 Training Program. 10. National Institute on Drug Abuse K23 (NIDA): Sun Kim, PhD, RN. 5 K23 DA021243-02 Tobacco Dependence Treatment for Asian Americans Primary Mentor: D. Ziedonis 04/01/2009-03/31/2014. $845,925 11. National Institute on Drug Abuse (NIDA) K23: Amy Wachholtz, PhD, M. Div. (PI) 1K23DA030397-01A1 Co-morbid Opioid Addiction and Chronic Pain Co Mentor: D. Ziedonis 08/16/2011-07/31/2016. $127,112 12. National Institute on Drug Abuse (NIDA) K01: Gina Vincent, PhD. 1 K01 DA026502-01A1. Neuroimaging Youth with Callous-Unemotional CD and Co-morbid Substance Abuse. Secondary Mentor: D. Ziedonis. Period 08/2010 07/2015. Total direct costs: $900,000. 13. Veterans Affairs Office of Patient Care Services: National Center for Homelessness Among Veterans Site PI David Smelson, Site Co-I Marsha Ellison, Doug Ziedonis, Gerardo Gonzalez. (overall Center PI s Kane, Casey, and Smelson). December 2009-November, 2014 $7,600,000. 14. VA National Center on Homelessness Among Veterans, Award. A Multi-Site Feasibility Study of Interventions Designed to Enhance HUD-VASH Services. PI David Smelson, Co-PI Gerardo Gonzalez, Co-I s Doug, Ziedonis, Jim McKay, Toorjo Ghose, Dave Oslin, Roger Casey, John Schinka. September 2010 September 2013. $300,000. 15. VA National Center on Homelessness Among Veterans, Award. Development of a Structured Toolkit to Assist HUD-VASH Case Managers in the Housing Placement and Treatment of Homeless Veterans with Clinical Needs. PI: David Smelson. Co-Doug Ziedonis. February 2011 September 2013. $200,00 16. VA National Center on Homelessness Among Veterans Award. Developing Technologies to Enhance Treatment Engagement. PI David Smelson. Co-I Doug Ziedonis April 2011 April 2013. $275,000. 17. Veterans Affairs HSR&D QUERI Grant # SDP 11-235. MISSION-Vet HUD VASH Implementation Study. PI David Smelson, Co-PI Matthew Chinman, Co-I s Allen Gifford, Marsha Ellison, David Kalman, Doug Ziedonis, Lisa Najavits, Karen Guthrie, Richard DeBlasio, Jesse Vazzano, Vincent Kane, Brian Mittman, Jeffrey Smith, Brian Mittman, Stephanie Rodrigues. October 2011 September 2015. $1,098,800.00 Douglas M. Ziedonis, MD, MPH 23

18. NIMH K-23 MH082098-01A1. Innovative Intervention Strategies for Metabolic Problems in Schizophrenia: Developing innovative intervention strategies for psychopathology, cognitive deficits, and metabolic problems in patients with schizophrenia. PI: Xiaoduo Fan. Primary Mentor: Doug Ziedonis. 06/12/2008-05/31/2014. $247,243. Past Grants: 1. R01 DA020705. Addressing Tobacco through Organizational Change. National Institute of Drug Abuse (NIDA). UMass site PI: Ziedonis. (Overall PI J. Guydish: UCSF; Co-PI: D. Ziedonis); 04/20/2006-03/31/2011. $1,400,000. 2. Veterans Integrated Service Network/VISN 1 Career Development Award: Megan Kelly, PhD. V1CDA2010-01). A Mindfulness and Acceptance-Based Smoking Cessation Treatment for Veterans with Posttraumatic Stress Disorder. Veterans Health Administration, U.S. Department of Veterans Affairs. Primary Mentor: D. Ziedonis. 2010-2012 $187,283. 3. VA National Center on Homelessness Among Veterans. Maintaining Independence and Sobriety Through Systems Integration Outreach and Networking: Manual and Workbook Development Project. PI David Smelson, Co-PI Gerardo Gonzalez, Co-I Doug Ziedonis. September 2010 February 2012. $175,000. 4. VA HSR&D Merit Review RRP 2010-2011 Addressing tobacco through organizational change in Veterans Administration Substance Disorder Programs (Kalman PI; Ziedonis Co-I) 5. SAMHSA GS-10F-0148P. Evaluation of the SAMHSA National Co-Occurring Disorder State Initiative Grant. Substance Abuse and Mental Health Services Administration (SAMHSA). UMass PI (overall PI: J. Hornik / Advocates for Human Potential, Co-PI: D. Ziedonis). UMass PI: D. Ziedonis 10/01/2005-03/31/2010. $750,000. 6. NIDA R03 DA024217 (DiFranza PI, King, Co-PI, Ziedonis, Co-I) 4/10/2008-3/31/2009 Imaging of nicotine sensitization in humans: a translational application of fmri. The goal is to determine if MRI can image sensitization in smokers brain; if so it may be possible to image human sensitization to all addictive drugs. 7. NIDA K23: Lisa Fortuna, MD. K23 DA14009-01. Adolescent Trauma and Addiction. NIDA Career Development Award (K23). Primary Mentor: D. Ziedonis. July 2006 July 2011. $850,000. 8. R01 DA15978-01. Modifying Motivational Enhancement Therapy (MET) for use with Addiction Severity Index (ASI) data. National Institute of Drug Abuse (NIDA). PI: D. Ziedonis; Co-PI: J. Krejci. 10/02 7/07. $931,724. 9. SF 424 (R&R) NIH Kratom as a Barrier to Drug Treatment of Opioid Analgesic Addiction, PI: Edward Boyer; Co:I: D. Ziedonis (UMMS) 4/1/09-3/31/11 $72,319 10. NIH / ARRA / NIDA RC1-08428 A Mobile Enabling Technology to Enhance Adherence to Behavioral Therapy. Clinical study of a mobile real-time detection and intervention technology for drug addicts with PTSD. (PI: E. Boyer; Co-I: D. Ziedonis) 10/01/2009-9/3/2011 Douglas M. Ziedonis, MD, MPH 24

11. Legacy Foundation (McKay, PI, Ziedonis, Co-I). Disseminating Tobacco Cessation Activities in ICCD Clubhouses. 12/1/08-11/30/10. $148,930. 12. VA HSR&DRRP 08-253 $75,000. Title: Addressing Tobacco Through Organizational Change in the Community Based outpatient Clinics. PI David Smelson, CO-I s Tatyana Sheinlukht, Doug Ziedonis, David Kalman September, 2009-September, 2010 13. R21DA025149-01A1 K Chen (PI) 4/1/2009 --- 3/31/2011 NIH/NIDA Treatment of Cocaine Addiction with Integrative Meditation This stage-ib behavior therapy development study will add Integrative Meditation to the outpatient treatment of cocaine addiction through a randomized control study of N=66 with supportive counseling as control. 14. R01 MH076672 NIMH. Nicotine Intake in Smokers with Schizophrenia. PI: J. Williams; Co-I: D. Ziedonis. 8/06 7/09. $1,568,392. 15. CSAT T116576. Maintaining Independence and Sobriety through Systems Integration, Outreach and Networking: Evaluation of the MISSION Program. Center for Substance Abuse Treatment, SAMHSA. November 2004 December 2009. PI: D. Smelson; Co-PI: A. Kline; Co-I s: D. Ziedonis, M. Losonczy. $1,968,071. 16. NIDA Minority Supplement for Modifying MET. NIDA Minority Supplement. PI: D. Ziedonis. 5/03 9/05. $40,000. 17. NIDA Re-Entry Supplement for Modifying MET. PI: D. Ziedonis. 6/05 6/07. $140,000. 18. R01 DA015537. Treatment of Addiction to Nicotine in Schizophrenia (Behavioral Therapy Development Study). National Institute of Drug Abuse (NIDA). PI: D. Ziedonis. 7/2003 6/2008. $1,513,905. PI role transferred in 4/07 to J. Williams upon move to UMass. 19. NIDA Minority Supplement for Treatment of Addiction to Nicotine in Schizophrenia. PI: D. Ziedonis. 9/04 9/06. $40,000. 20. NIDA Re-Entry Supplement for Treatment of Addiction to Nicotine in Schizophrenia. PI: D. Ziedonis. 7/05 5/07. $140,000. 21. NIDA / VA CSP-1022. Phase 2, Double-blind, Placebo-controlled trial of Selegiline Transdermal System (STS) as an aid for smoking cessation. UMDNJ transferred to Jill Williams upon move to UMMS. Site PI: D. Ziedonis (NIDA multi-center collaborative study). 10/06 9/08. $451,491. 22. Community Partnership: Addressing Tobacco in Mercer County. NJ Department of Health and Senior Services. PI: D. Ziedonis. 7/1/06 6/30/09. $240,000. Transferred to Mark Steinberg upon move to UMass. 23. Nicotine Dependence Treatment Program and Evaluation. NJ Department of Health and Senior Services. PI: D. Ziedonis. 11/1/00 6/30/09. $907,000. PI role transferred to M. Steinberg upon move to UMass. Douglas M. Ziedonis, MD, MPH 25

24. KD1 TI12549-01. Consultant versus Fully Integrated Treatment for Co-Occurring Disorders. Substance Abuse and Mental Health Services Administration (SAMHSA): Center for Substance Abuse Treatment (CSAT). PI: D. Ziedonis. 10/1/00 8/30/04, $1.15 million. 25. Buprenorphine / Naloxone versus Clonidine for Outpatient Opioid Detoxification. National Institute on Drug Abuse. PI: D. Ziedonis. National Multi-site Study within the Clinical Trials Network of NIDA. 11/01/00 8/31/02 $291,769 26. Clinical Trial Network Community Treatment Provider Research Core. National Institute of Drug Abuse. PI (Robert Wood Johnson Medical School): D. Ziedonis. 9/30/99 8/31/09. (part of NIDA s University of Pennsylvania/Delaware Valley Node in the Clinical Trial Network) $133,333. 27. NIDA K23 Award: Jill Williams, MD. Nicotine Dependence Treatment in Psychiatric Comorbidity. K23 DA14009-01. NIDA Career Development Award (K23). Primary Mentor: D. Ziedonis. July 2001 July 2006. $700,000. 28. NIDA K23 Award: Edwin Boudreaux, PhD. Tobacco treatment initiated in the emergency department. K23 DA016698. NIDA Career Development Award. Primary Mentor: D. Ziedonis. July 2003 2008. $800,000. 29. NIDA K23 Award : Marc Steinberg, PhD. Treatment Issues for Smokers with Schizophrenia. K23 DA018203-01 NIDA Career Development Award. Primary Mentor: D. Ziedonis. July 2004 June 2009. $597,725. 30. NIDA Re-Entry Career Award: Adriana Cordal, MD. Enhancing Motivation in Drug Addiction Treatment. (50% Research Salary Support). National Institute of Drug Abuse. Mentor: D. Ziedonis. June 2005 July 2007. $280,000. 31. CINJ Career Award: Jonathan Foulds, PhD. Tobacco Dependence Treatments for Cancer Prevention. Cancer Institute of New Jersey (CINJ) Faculty Development Award. Primary Mentor: D. Ziedonis. January 2005 January 2007. $180,000. 32. CINJ Career Award: Michael Steinberg, MD. Engaging and Treating Tobacco Dependence Amongst the Medically Ill for Cancer Prevention. Cancer Institute of New Jersey (CINJ) Faculty Development Award. Primary Mentor: D. Ziedonis. January 2005 January 2007. $180,000. 33. NIMH K23 Award: Philip Yanos, PhD. Coping and Recovery in Serious Mental Illness. NIMH K23 Career Development Award. Primary Mentor: D. Mechanic. Secondary Mentor: D. Ziedonis. July 2003 2008. $750,000. 34. Risperidone vs Haloperidol in Treating Individuals with Schizophrenia or Schizoaffective Disorder Who Continue to Use Alcohol and/or Cocaine. PI: D Ziedonis. Janssen Research Foundation. 6/99 5/01 $107,844. 35. Drug Abuse and Psychiatric Co-Morbidity. National Institute of Drug Abuse Career Development Award: (Scientist Development Award for Clinicians, SDAC). PI: D. Ziedonis. National Institute of Drug Abuse # K20-DA0193; 1993 1999. $573,692. Douglas M. Ziedonis, MD, MPH 26

36. Therapy for Drug Abusers with Psychiatric Co-morbidity. PI: D. Ziedonis. National Institute of Drug Abuse # RO1-DA09127-01A1. 1995 1999. $508,212. 37. Pharmacotherapy for Schizophrenic Cocaine Abusers, Core Project. PI: D. Ziedonis, $1,250,100. Core Project within the Yale Medications Development Research Center. PI: T. Kosten. National Institute of Drug Abuse. # P50DA09250. 1994 1999. $7,386,870. 38. Nicotine Dependence and Psychiatric Patients Smoking Cessation Treatment Development, Pilot Project PI: D. Ziedonis. $55,000. 1997 1998. Pilot project within the Yale Psychotherapy Development Research Center. Center, PI: B. Rounsaville. National Institute of Drug Abuse. # P50DA09241-01. $7,742,207. 39. Risperdal versus Haloperidol in the Treatment of Substance Abusing Schizophrenics. PI: D. Ziedonis. Janssen Research Foundation. 1997 1999. $156,600. 40. R01 MH076068-01A1 NIMH, "Critical Time Intervention (CTI) for Men with Mental Illness Leaving Prison." PI: J. Draine (University of Pennsylvania); Co-I: D. Ziedonis (UMDNJ). 10/06 9/11. $3,486,675. 41. Tobacco Dependence Program. NJ Department of Health and Senior Services. New Jersey State Government, Trenton. Period: 7/1/00 6/30/07. PI: J. Foulds; Co-PI: D. Ziedonis. $7,091,202 42. Using Peer Counselors to Address Tobacco among Mental Health Consumers. American Legacy Foundation, Small Innovative Grant Program. Term 2005 2007 PI: J. Williams; Co-PI: D. Ziedonis. $100,000. 43. Office Based Treatment for Addictions: Therapy Development Study. Robert Wood Johnson Foundation. PI: S. Adtjian; Co-PI: D. Ziedonis. September 1, 2000 December 31, 2003. $460,000. 44. Addressing Tobacco Project. NJ Department of Health and Senior Services. New Jersey State Government, Trenton. Period: 1 May, 2000 30 June, 2000. PI: J. Slade; Co-PI: D. Ziedonis, $148,687. 45. P20-MH-074634-01. Medically Unexplained Physical Symptoms (MUPS) in Primary Care Research Center. Developing Center Grant. National Institute of Mental Health. September 2005 August 2010, PI: J. Escobar; Co-I s: D. Ziedonis, M. Menza. $2,911,462. 46. VA HSRandD Merit Review Grant # IIR-020-145. Title: A Brief Community Linkage Intervention for Dually Diagnosed individuals. PI: D. Smelson; Co-I s: M. Losonczy, A. Kline, B. Sussner, D. Ziedonis, F. Blow. February 2005 February 2009. $686,909. 47. Veterans Administration Award. Time-Limited Case management for Chemically Addicted Mentally Ill. PI: D. Smelson; Co-PI: A. Kline; Co-I s: B. Sussner, M. Losonczy, D. Ziedonis. May 2005 May 2008. $864,434. 48. National Institute for Health Grant # R21 AT001350 Title: Qigong Therapy for Treating Cocaine Addiction. National Center for Complementary and Alternative Medicine PI: D. Smelson; Co-I: K. Chen, D. Ziedonis, A. Kline. June 2005 May 2008. $586,063. Douglas M. Ziedonis, MD, MPH 27

49. R03 DA020434-01. Cue-elicited Craving and Genetics in Cocaine Dependence. National Institute Drug Abuse. PI: D. Smelson; Co-I s: P. Manowitz, J. Tishfield, A. Kline, P. Lehrer, B. Sussner, D. Ziedonis. National Institute of Health R03 DA020434-01. September 2005 September 2007. $155,500. 50. Clinical Trials Network Center Grant (Delaware Valley Node). Funded by the National Institute of Drug Abuse for term 1999 2004. PI: G. Woody, University of Pennsylvania; Co-I and Project Director New Jersey Sites: D. Ziedonis. $11,000,000. 51. Mental Illness Research and Education Clinical Center (MIRECC). Funded by the Veterans Affairs Central Office. 1/1/99 12/31/04. PI: L. Siever, Bronx VA / Mt. Sinai; Co-I: D. Ziedonis. $9,000,000. 52. RO1: AA 11639. Inherited Susceptibility to Alcoholism. National Institute of Alcoholism and Alcohol Abuse. 7/1/99 6/30/03. PI: P. Manowitz; Co-I: D. Ziedonis. $600,356. 53. NIDA R01. Adapting Behavioral Marital Therapy to Treat Drug Abusers. Funded by the National Institute of Drug Abuse. PI: E. Epstein, Rutgers University Center for Alcohol Studies; Co-I: D. Ziedonis. 7/1/99 6/30/02. $550,000. 54. The efficacy of aripiprozal in decreasing cue-elicited craving in withdrawn cocaine dependent patients. PI: D. Smelson; Co-I: D. Ziedonis. Bristol Myer Squibb. 2003 2005. $49,100. 55. A study of the efficacy of seroquel in decreasing cue-elicited craving and relapse in withdrawn cocaine dependent patients. PI: D. Smelson; Co-I: D. Ziedonis. Astra Zeneca. 2002 2004. $89,250. 56. The efficacy of risperidone as an anti-cocaine craving agent in withdrawn cocaine dependent patients. PI: D. Smelson; Co-I: D.Ziedonis. Janssen Research Foundation. 2002 2004. $59,100. 57. Veterans Administration Millennium Funding. Evaluation of the Transitional Treatment Interventions-Time-limited Case Management. PI: D. Smelson; Co-I s: M. Losonczy, D. Ziedonis. 2000 2003. $414,000. 58. The Efficacy of Risperidone in decreasing cue-elicited craving in withdrawn cocaine dependent schizophrenics. PI: David Smelson; Co-I s: M. Losonczy, D. Ziedonis. Janssen Research Foundation. Feb. 1999 Jan. 2001. $43,500. 59. R41 DA021455-01 NIDA. The Dynamic Assessment and Referral System for Substance Abuse (DARSSA). PI: E. Boudreaux; Consultant: D. Ziedonis $145,852. 60. The Efficacy of Olanzapine versus Haloperidol in decreasing cue-elicited craving and relapse in withdrawn cocaine dependent schizophrenics. PI: D. Smelson; Co-PI: D. Ziedonis. Lilly Pharmaceutical. 1/99 12/00. $59,000. 61. Nicotine, nicotine patch, and the impact on pulmonary isoenzymes: a pilot study. Funded by Rutger s University. PI: M. Iba, EOSHI, Rutger s University; Co-PI: D. Ziedonis. 1/1/00 12/31/00. $15,000. Douglas M. Ziedonis, MD, MPH 28

62. Yale Faculty Alcohol and Drug Training Cadre Program. PI: R. Shottenfeld. National Institute of Drug Abuse. 1992 1997. $597,378. 63. Yale Medications Development Research Center. Center PI: T. Kosten. National Institute of Drug Abuse. # P50DA09250. 1994 1999. $7,386,870. 64. Connecticut Department of Mental Health / Yale Medication Effectiveness Research Program. PI: S. Woods. NIMH # R24 MH54446. 1994 1999. $2,317,916. 65. Medication Development Research Center. Center PI: T. Kosten, NIDA # P50DA09250. 1995 1998. $7,386,870. 66. Research Training in Mental Health Epidemiology. PI: K. Merikangas. National Institute of Mental Health. 1995 2000. $1,455,574. 67. Yale Psychotherapy Development Research Center. Center PI: B. Rounsaville. National Institute of Drug Abuse. # P50DA09241-01. 1994 1999. $7,742,207. Service Grants / Pilot Research Clinical Programs at UMDNJ: UMDNJ s University Behavioral Health Care Addiction Services: As Director of UBHC s Addiction Services, my role was to oversee the application for these grants and to monitor the progress of these grants and the related service delivery. Some of these grants also had a program evaluation component: 1. Women s Outpatient Addiction Services. Funding agency: Department of Health Senior Services; Amount awarded yearly: $65,602; Expiration: 8/31/05. 2. Deaf and Hard of Hearing Addiction Services. Funding agency: Department of Health Senior Services; Amount awarded yearly: $38,298; Expiration: 8/31/05. 3. Mercer Trenton Addiction Science Center. Funding agency: Mercer County; Amount awarded yearly: $311,885; Expiration: 8/31/05. 4. Mercer County Accessing Seniors Addiction Program. Funding agency: Mercer County; Amount awarded yearly: $45,000; Expiration: 12/31/05. 5. Addiction Screening Program. Mercer County; yearly: $28,620; Expiration: 12/31/05. 6. Addiction Screening for Kids (ASK). Funding agency: Mercer County; Amount awarded yearly: $65,296; Expiration: 6/30/06. 7. Adult Corrections Addiction Services. Funding agency: Middlesex County Human Services Department; Amount awarded yearly: $31,806. Expiration: 6/30/06. 8. HIV Prevention Outreach. Funding agency: Middlesex County Department of Health; Amount awarded yearly: $26,467; Expiration: 3/31/06. 9. Changing Habits and Responsibly Living in my Environment (CHARLIE). Healthy Mothers / Healthy Babies Coalition; $39,898; Expiration: 6/30/06. 10. Alcoholism Treatment Adult Outpatient. Funding agency: Middlesex County; Amount awarded yearly: $70,000; Expiration: 12/31/06. 11. Treatment and Evaluation for Addicted Minorities (TEAM) Outpatient Addiction Services. Funding agency: Middlesex County; yearly: $63,000. Expiration: 12/31/06. 12. Adult Outpatient Addiction Services. Funding agency: Middlesex County; Amount awarded yearly: $63,000; Expiration: 12/31/06. 13. Adolescent Recovering Together Intensive Outpatient Addiction Services. Funding agency: Middlesex County; Amount awarded: $80,000; Expiration: 12/31/06. Douglas M. Ziedonis, MD, MPH 29

PUBLICATIONS: A. Articles in Journals 1. Townsend, J.B., Ziedonis, D.M., Bryan, R.M., Brennan, R.W., and Page, R. Choroid Plexus Blood Flow: Evidence of Dopaminergic Control. Journal of Cerebral Blood Flow and Metabolism 3(supp1): s216-7, 1983. 2. Townsend, J.B., Ziedonis, D.M., Bryan, R.M., Brennan, R.W., and Page, R. B. Choroid Plexus Blood Flow: Evidence for Dopaminergic Influence. Brain Research 290:165-9, 1984. 3. Cadieux, R.J. and Ziedonis, D.M. Dementia: Differential Diagnosis and Evaluation. Family Practice Recertification 7(12):55-90, 1985. 4. Ziedonis, D.M., Servers, W.B., Brennan, R.W., and Page, R.B. Blood Flow and Functional Responses Correlate in the Ovine Neural Lobe. Brain Research 373:27-34, 1986. 5. Ziedonis, D.M., Ungerleider, J.T., and Noble, E.P. Teaching Substance Abuse Using an Interactive Teaching Model. Substance Abuse 10(2):97-102, 1989. 6. Ziedonis, D.M. and Kosten, T.R. Depression as a Prognostic Factor for Pharmacological Treatment of Cocaine Dependence. Psychopharmacology Bulletin 27:337-343, 1991. 7. Ziedonis, D.M. and Kosten, T.R. Pharmacotherapy Improves Treatment Outcome In Depressed Cocaine Addicts. Journal of Psychoactive Drugs 23(4): 417-425, 1991. 8. Kosten, T.R., Rosen, M., Schottenfeld, R., and Ziedonis, D.M. Buprenorphine for Cocaine and Opiate Dependence. Psychopharmacology Bulletin 28(1):15-19, 1992. 9. Jenkins, S.W., Warfield, N.A., Blaine, J.D., Cornish, J., Ling, W., Rosen, M., Urschel, H., Wesson, D., and Ziedonis, D.M. A Pilot Trial of Gepirone versus Placebo in the Treatment of Cocaine Dependence. Psychopharmacology Bulletin 28(1), 1992. 10. Ziedonis, D.M., Richardson, R., Lee, E., Petrakis, I., and Kosten, T. Adjunctive Desipramine in the Treatment of Cocaine Abusing Schizophrenics. Psychopharmacology Bulletin 28(3):309-314, 1992. 11. Ungerleider, J.T, Pechnick R., Wallbom, A.S., Siegal, N., Fairbanks, L., Ziedonis, D.M. Interactive Teaching, Medical Students and Substance Abuse: University and Community Join Together in New Endeavor. Academic Psychiatry 16(3):160-169, 1992. 12. Ziedonis, D.M. and Kosten, T.R. Behavioral Pathology (Substance use disorder classification and subtyping). Annual Review of Addictions Research and Treatment 2:109-123, 1992. 13. Ziedonis, D.M. Diagnosing and Treating Comorbid Psychosis and Substance Abuse. Current Approaches to Psychoses 2:6-12, 1993. Douglas M. Ziedonis, MD, MPH 30

14. Carroll, K., Ziedonis, D.M. O'Malley, S., Kosten, T.R., and Rounsaville, B.J. Pharmacological Interventions for Abusers of Alcohol and Cocaine: Disulfiram versus Naltrexone. The American Journal on Addictions 2(1): 77-79, 1993. 15. Schottenfeld, R.S., Pakes, J.R., Ziedonis, D.M., and Kosten, T.R. Buprenorphine: Dose-Related Effects on Cocaine and Opioid Use in Cocaine Abusing Opioid-Dependent Humans. Biological Psychiatry 34:66-74, 1993. 16. Kosten, T.R., Schottenfeld, R., Ziedonis, D.M., and Falcioni, J. Buprenorphine versus Methadone Maintenance for Opioid Dependence. Journal of Nervous and Mental Disease 181:358-364, 1993. 17. Oliveto, A., Kosten, T.R., Schottenfeld, R.S., and Ziedonis, D.M. Cocaine Abuse Among Methadone-Maintained Patients. American Journal of Psychiatry 150:1755, 1993. 18. Ziedonis, D.M., Rayford, B.S., Bryant, K., and Rounsaville, B.J. Psychiatric Comorbidity in White and African-American Cocaine Addicts Seeking Substance Abuse Treatment. Hospital and Community Psychiatry 45:43-49, 1994. 19. Oliveto, A., Kosten, T.R., Schottenfeld, R., Ziedonis, D.M., and Falcioni, J. Cocaine Use in Buprenorphine versus Methadone Maintained Patients. American Journal of Addictions 3:43-48, 1994. 20. Ziedonis, D.M., Kosten, T.R., Glazer, W.M., and Frances, R.J. Nicotine Dependence and Schizophrenia. Hospital and Community Psychiatry 45:204-206, 1994. 21. Leal, J., Ziedonis, D.M., and Kosten, T.R. Antisocial Personality Disorder as a Prognostic Factor for Pharmacotherapy of Cocaine Dependence. Drug and Alcohol Dependence 35:31-35, 1994. 22. Ziedonis, D.M., Rao, S., and Preisig, M. Comorbidity Blues: Diagnosing and Treating Depression among Substance Abusers. Employee Assistance 6:6-34, 1994. 23. Ziedonis, D.M. and Fischer, W. Assessment and Treatment of Comorbid Substance Abuse in Individuals with Schizophrenia. Psychiatric Annals 24:477-483, 1994. 24. George, T., Sernyak, M.J., Ziedonis, D.M., and Woods, S.W. Effects of Clozapine on Smoking In Chronic Schizophrenic Outpatients. Journal of Clinical Psychiatry 56:344-346, 1995. 25. Farren, C.K., Ziedonis, D.M., Clare, A.W., Hameedi, F.A., and Dinan, T.G. D-Flenfluramine induced prolactin response in post-withdrawal Alcoholics and Controls. Alcoholism: Clinical and Experimental Research 19:1578-1582, 1995. 26. Farren, C.K., Clare, A.W., Ziedonis, D.M., Hammeedi, F.A., and Dinan, T.G. Evidence for reduced dopamine D2 receptor sensitivity in post-withdrawal alcoholics. Alcoholism: Clinical and Experimental Research 19:1520-1524. 1995. Douglas M. Ziedonis, MD, MPH 31

27. Oliveto, A., Kosten, T., Schottenfeld, R., Falcioni, J., and Ziedonis, D.M. Desipramine, Amantadine, or Fluoxetine in Buprenorphine Maintained Cocaine Users. Journal of Substance Abuse Treatment 12:423-428, 1995. 28. Schottenfeld, R.S., Pakes, J., Ziedonis, D.M., and Kosten, T.R. Buprenorphine: Dose-Related Effects on Cocaine and Opioid Use in Cocaine Abusing Opioid-Dependent Humans. Yearbook of Psychiatry and Applied Mental Health, 5:160-161, 1995 29. Rao, S., Ziedonis, D.M., and Kosten, T.R. The Pharmacotherapy for Cocaine Dependence. Psychiatric Annals 25:363-368, 1995. 30. Ziedonis, D.M. and Fisher, W. Motivation Based Assessment and Treatment of Substance Abuse in Patients with Schizophrenia. New Directions in Psychiatry 16:1-8, 1996. 31. Ziedonis, D.M. and Kosten, T.R. Nicotine Dependence and Schizophrenia. Italian Journal of the Addictions 4:44-47, 1996. 32. Hughes, J.R., Fiester, S., Goldstein, M., Resnick, M., Rock, N., and Ziedonis, D.M. American Psychiatric Association s Practice Guidelines for the Treatment of Patients With Nicotine Dependence. American Journal of Psychiatry 153(10, entire supplement), 1996. 33. Ziedonis, D.M. and Trudeau, K. Motivation to Quit Using Substances Among Individuals With Schizophrenia: Implications for a Motivation-Based Treatment Model. Schizophrenia Bulletin 23(2):229-238, 1997. 34. Kosten, T. and Ziedonis, D.M. Substance Abuse and Schizophrenia. Schizophrenia Bulletin 23(2):181-186, 1997. 35. Ziedonis, D.M. and Brady, K. Dual Diagnosis in Primary Care. Medical Clinics of North America 81(4):1017-1036, 1997. 36. Ziedonis, D.M. and George, T.P. Schizophrenia and Nicotine Use: Report of a Pilot Smoking Cessation Program and Review of Neurobiological and Clinical Issues. Schizophrenia Bulletin 23(2):247-254, 1997. 37. Schottenfeld, R.S., Pakes, J.R., Oliveto, A., Ziedonis, D.M., and Kosten, T.R. Buprenorphine versus Methadone Maintenance For Concurrent Opioid Dependence and Cocaine Abuse. Archives of General Psychiatry 54(8):713-720, 1997. 38. Kraus, M.L., Ziedonis, D.M., Feinberg, M.A., Segal, S.R., Israel, L., and Kraus, M. A Community Hospital s Ambulatory Addiction Medicine Program. Connecticut Medicine 62:89-93, 1998. 39. Smelson D.A., Roy M., Roy A., Engelhart C., Williams J., and Ziedonis D. Relationship between Electroretinogram, Blue Cone Amplitude, and Cue Elicited Cocaine Craving. In L. Harris (Ed), Problems of Drug dependence, 1999. National Institute on Drug Abuse Research Monograph. Washington DC: USGPO, 2000. Douglas M. Ziedonis, MD, MPH 32

40. Ziedonis D., Williams J. Corrigan, P., and Smelson D. Management of Substance Abuse in Schizophrenia. Psychiatric Annals 30(1):67 75, 2000. 41. Woods, S., Ziedonis, D.M., Sernak, M., Diaz E., and Rosenheck R. Characteristics of Participants and Non-participants in Medication Trials for Treatment of Schizophrenia. Psychiatric Services 51:79-84, 2000. 42. George T.P., Ziedonis D.M., Feingold A., Pepper W.T., Satterburg C.A., Winkel J., Rounsaville B.J., and Kosten T.R. Nicotine Transdermal Patch and Atypical Antipsychotic Drugs for Smoking Cessation in Schizophrenia. American Journal of Psychiatry 157 (11):1835-1842, 2000. 43. McCrady B. and Ziedonis D. American Psychiatric Association Guideline for Substance Use Disorders. Journal of Behavioral Therapy 32:309-336, 2001. 44. Carol G., Smelson D., Losonczy M.F., Ziedonis D. A preliminary investigation of cocaine craving among persons with and without schizophrenia. Psychiatric Services 52:1029-1031, 2001. 45. Ziedonis D. and Stern, R. Dual Recovery Therapy for Schizophrenia and Substance Abuse. Psychiatric Annals 31(4):255 264, 2001. 46. Smelson D.A., Davis C.W., DiPano, R., Johnson V., Losonczy M.F., Ziedonis, D.M. Executive and motor skill functioning among cocaine-dependent schizophrenics and nondrug-abusing schizophrenics. Journal of Nervous Mental Disorders 190(3):200-202, 2002. 47. Smelson, D.A., Losonczy, M., Kaune, M., Williams, J., Davis, C., Ziedonis, D.M. Risperidone decreases cue-elicited craving and relapses in withdrawn cocaine-dependent schizophrenics. Schizophrenia Research 53:160, 2002. 48. Krejci, J. and Ziedonis, D.M. Medications in the treatment of addiction: workplace issues. Occupational Medicine. 17(1):91-104, 2002. 49. Roeloffs C., Wells K., Ziedonis D.M., Tang L., Unutzer J. Problem substance use among depressed patients in managed primary care. Psychosomatics 43(5):405-12, 2002. 50. Brewster T, Farentinos C, Ziedonis D. Response: the neurobiological model in community treatment programs. Sci Pract Perspect. 2002 Jul;1(1):21. 51. Smelson, D.A., Losonczy M.F., Davis C.W., Kaune M., Williams J., Ziedonis D. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Canadian Journal of Psychiatry 47(7):671-5, 2002. 52. Ziedonis, D.M. and Williams, J. When Psychosis and substance use coincide in the emergency service. Psychiatric Issues in Emergency Care Settings. Summer Issue: 3 13, 2002. 53. Williams, J. and Ziedonis, D.M. Emergency management of psychosis and substance abuse. Psychiatric Issues in Emergency Care Settings. Summer Issue: 14 19, 2002. Douglas M. Ziedonis, MD, MPH 33

54. Smelson, D.A., Starosta A., Losonczy M.F., Kind J., Williams J., and Ziedonis D. An Analysis of Cue Reactivity Among Individuals With Schizophrenia Compared to Cocaine Addicts Without Schizophrenia. Psychiatric Services 53:1612-1616, 2002. 55. Smelson, D.A., Losonczy, M., Kaune, M., Williams, J., Davis, C., Ziedonis, D.M. Risperidone decreases cue-elicited craving and relapses in withdrawn cocaine-dependent schizophrenics. Schizophrenia Research 53:160, 2002. 56. Brewster, T., Farentinos C., Ziedonis, D. Response: implementing motivational stepped care. Sci Pract Perspect. Jul 1(1):47-8, 2002. 57. Krejci, J., Steinberg, M.L., and Ziedonis, D.M. Smoking status and substance abuse severity in a residential treatment sample. Drug and Alcohol Dependence 72, 249-254, 2003. 58. Ziedonis, D.M. Williams, J.M. Smelson, D.A. Serious Mental Illness and Tobacco Addiction: A Model Program to Address this Common but Neglected Issue. American Journal of the Medical Sciences 326(4):223-30, 2003. 59. Smelson, D.A., Davis, C., Eisenstein, N., Engelhart, C., Williams, J., Losonczy., M.F. and Ziedonis, D.M. Cognitive disparity in schizophrenics with and without cocaine dependency. Journal of Substance Abuse Treatment 24(1) 75-79, 2003. 60. Williams, J.M. and Ziedonis, D. Naltrexone-bupropion combination therapy for protracted abstinence dysphoria. The American Journal on Addictions 2(3):270-272, 2003. 61. Kampov-Polevoy, A.B., Ziedonis, D.M., Steinberg, M.L., Pinsky, I., Krejci, J.A., Eick, C., Boland, G., Khalitov, E., and Crews, F.T. Association between sweet preference and paternal history of alcoholism in psychiatric and substance abuse patients. Alcoholism: Clinical and Experimental Research 27(12):1929-1936, 2003. 62. Ziedonis, D.M. and Williams, J. Management of Smoking in People with Psychiatric Disorders. Current Opinion in Psychiatry. 16 (3):305-315, 2003. 63. Smelson, D.A., Ziedonis, D.M., Losonczy, M.F., Williams, J., and Kaune, M. A double-blind study comparing olanzapine to haloperidol for reducing cue-elicited craving in individuals with schizophrenia and cocaine dependence. Schizophrenia Research 60(1):303, 2003. 64. Ziedonis, D.M. and Williams, J. Addressing Tobacco Use in Mental Health and Addiction Settings. Psychiatric Annals. 33(7):425-426, 2003. 65. Stuyt, E.B., Order-Connors, B., and Ziedonis, D.M. Addressing Tobacco through Program and System Change in Mental Health and Addiction Settings. Psychiatric Annals. 33(7):446-456, 2003. 66. Steinberg, M.L., Ziedonis, D.M., Krejci, J.A., and Brandon, T.H. Motivational Interviewing With Personalized Feedback: A Brief Intervention for Motivating Smokers with Schizophrenia To Seek Treatment for Tobacco Dependence. Journal of Consulting and Clinical Psychology 72(4):723-728, 2004. Douglas M. Ziedonis, MD, MPH 34

67. Williams J.M., Ziedonis D.M., Foulds J. Case Series of Nicotine Nasal Spray in the Combination Treatment of Tobacco Dependence among Patients with Schizophrenia. Psychiatric Services 55(9):1064-1066, 2004. 68. Williams, J.M. and Ziedonis, D.M. Addressing Tobacco among Individuals with a Mental Illness or an Addiction. Addictive Behaviors. 29(6):1067-1083, 2004. 69. Foulds, J., Burke, M., Steinberg, M., Williams, J.M. and Ziedonis, D.M.. Advances in Pharmacotherapy for Tobacco Dependence. Expert Opinion in Emerging Drugs. 9(1):39-51, 2004. 70. Smelson, D.A., Williams, J., Ziedonis, D.M., Sussner, B.D., Losonczy, M.F., Engelhart, C., and Kaune, M. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. Journal of Substance Abuse Treatment 27:45-49, 2004. 71. Steinberg, M.L., Williams, J.M., and Ziedonis, D.M. Financial Implications of Cigarette Smoking Among Individuals with Schizophrenia. Tobacco Control 13(2):206, 2004. 72. Amass, L., Ling, W., Freese, T.E., Reiber, C., Annon, J.J., Cohen, A.J., McCarty, D., Reid, M., Brown, L.S., Clark, C., Ziedonis, D.M., Krejci, J., Stine, S., Winhusen, T., Brigham, G., Babcock, D., Muir, J., Buchan, B., Horton T. Bringing Buprenorphine-Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience. American Journal on Addictions 13:S42-S66, 2004. 73. Ziedonis, D.M. Integrated treatment of co-occurring mental illness and addiction: clinical intervention, program, and system perspectives. CNS Spectrum 9(12):892-904, 925, 2004. 74. Steinberg, M.L., Williams, J.M., Steinberg, H.R., Krejci, J.A., Ziedonis, D.M. Applicability of the Fagerström Test for Nicotine Dependence in Smokers with Schizophrenia. Addictive Behaviors 30(1):49-59, 2005. 75. Boudreaux, E.D., Baumann, B.M., Friedman, K., Ziedonis, D.M. Smoking Stage of Change and Interest in an Emergency Department-based Intervention. Academic Emergency Medicine 12(3):211-8, 2005. 76. Ling, W., Amass, L., Shoptaw, S., Annon, J.J., Hillhouse, M., Babcock, D., Brigham, G., Harrer, J., Reid, M., Muir, J., Buchan, B., Orr, D., Woody, G., Krejci, J., Ziedonis, D.M. Buprenorphine Study Protocol Group. A multi-center randomized trial of buprenorphinenaloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction 100(8):1090-100, 2005. 77. Mordan, E., Weeks, A., Geffrard, M., Baumann, B.M., Camargo, C.A., Jr., Ziedonis, D.M., Boudreaux, E.D. Expired carbon monoxide validation of self-reported smoking among ED patients. Academic Emergency Medicine 12(5):45, 2005. Douglas M. Ziedonis, MD, MPH 35

78. Williams, J.M., Foulds, J., Dwyer, M., Order-Connors, B., Springer, M., Gadde, P., Ziedonis, D.M. The Integration of Tobacco Dependence Treatment into Residential Addictions Treatment in New Jersey. Journal of Substance Abuse Treatment 28:331 340, 2005. 79. Boudreaux, E.D., Baumann, B.M., Camargo, C.A., Foulds, J., Ziedonis, D.M. Smoking among adult emergency department patients: Abstinence and stage of change one month post-visit. Annals of Behavioral Medicine 29S:29, 2005. 80. Walters, S.T., Matson, S.A., Baer, J.S., Ziedonis, D.M. Effectiveness of workshop training for psychosocial addiction treatments: A systematic review. Journal Substance Abuse Treatment 29(4):283-93, 2005. 81. Smelson, D.A., Losonczy, M., Castles-Fonseca, K., Stewart, P., Kaune, M., and Ziedonis, D.M. Preliminary Outcomes from a booster case management program for individuals with a co-occurring substance abuse and a persistent psychiatric disorder. Journal of Dual Diagnosis 13:47 59, 2005. 82. Ziedonis, D.M., Smelson, D.A., Rosenthal, R.N., Batki, S.L., Green, A.I., Henry, R.J., Montoya, I., Parks, J., Weiss, R.D. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatric Practice 11(5):315-39, 2005. 83. Williams, J.M., Ziedonis, D.M., Abanyie, F., Steinberg, M.L., Foulds, J., Benowitz, N.L. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder are not a metabolic effect. Schizophrenia Research 15;79(2-3):323-35, 2005. 84. Sussner, B.D., Smelson, D.A., Rodrigues, S., Kline, A., Losonczy, M., Ziedonis, D.M. The validity and reliability of a brief measure of cocaine craving. Drug and Alcohol Dependence Dec 26, 2005. 85. Smelson, D.A., Ziedonis, D.M., Williams, J., Losonczy, M.F., Williams, J., Steinberg, M.L., Kaune, M. The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report. J Clin Psychopharmacol 26(1):9-12, 2006. 86. Ziedonis, D.M., Williams, J.M., Steinberg, M., Foulds, J. Addressing tobacco addiction in office-based management of psychiatric disorders: practical considerations. Primary Psychiatry 13(2):51-63, 2006. 87. Foulds, J., Steinberg, M.B., Williams, J.M., Ziedonis, D.M. Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug Alcohol Rev 25(1):59-71, 2006. 88. Yanos, P.T., Ziedonis, D.M. The patient-oriented clinician-researcher: advantages and challenges of being a double agent. Psychiatric Services 57(2):249-53, 2006. 89. Work Group on Substance Use Disorders: Kleber, H.D., Weiss, R.D., Anton, R.F., Rounsaville, B.J., George, T.P., Strain, E.C., Greenfield, S.F., Ziedonis, D.M., Kosten, T.R., Hennessy, G., O Brien, C.P., Connery, H.S. American Psychiatric Association Steering Douglas M. Ziedonis, MD, MPH 36

Committee on Practice Guidelines; McIntyre, J.S., Charles, S.C., Anzia, D.J., Nininger, J.E., Cook, I.A., Summergrad, P., Finnerty, M.T., Woods, S.M., Johnson, B.R., Yager, J., Pyles, R., Lurie, L., Cross, C.D., Walker, R.D., Peele, R., Barnovitz, M.A., Gray, S.H., Shemo, J.P., Saxena, S., Tonnu, T., Kunkle, R., Albert, A.B., Fochtmann, L.J., Hart, C., Regier, D.. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. American Journal of Psychiatry. 163(8 Suppl):5-82, 2006. 90. Williams, J.M., Ziedonis, D.M. Snuffing out tobacco dependence. Ten reasons behavioral health providers need to be involved. Behavioral Healthcare 26(5):27-31, 2006. 91. Ziedonis, D.M., Haberstroh, S., Hanos Zimmermann, M., Miceli, M., Foulds, J. Adolescent tobacco use and dependence: assessment and treatment strategies. Adolescent Medicine Clinics 17(2):381-410, 2006. 92. Hu, H.M., Kline, A., Huang, F.Y., Ziedonis, D.M. Detection of co-occurring mental illness among adult patients in the New Jersey substance abuse treatment system. Am J Public Health 96(10):1785-93, 2006. 93. Boudreaux, E.D., Baumann, B.M., Foulds, J., Camargo, C.A. Jr., Ziedonis, D.M. The effect of removing cost as a barrier to treatment initiation with an outpatient tobacco dependence clinic among emergency department patients. Academic Emergency Medicine S373, 2006. 94. Foulds, J., Williams J, Order-Connors, B., Edwards N., Dwyer, M., Kline A., Ziedonis, D.M. Integrating tobacco dependence treatment and tobacco-free standards into addiction treatment: New Jersey s experience. Alcohol Res Health 29(3):236-240, 2006. 95. Boudreaux, E.D., Baumann, B.M., Foulds, J., Camargo, C.A. Jr., Perry, J., Ziedonis, D.M. An exploratory study of ED-initiated tobacco interventions: Deriving parameter estimates to plan randomized trials. Academic Emergency Medicine S309, 2006. 96. Ziedonis, D.M., Guydish, J., Williams, J., Steinberg, M., Foulds, J. Barriers and Solutions to Addressing Tobacco Dependence in Addiction Treatment Programs. Alcohol and Tobacco: an Update, Alcohol Research and Health, 29(3), 228-235, 2006. Retrieved from http://www/tobaccoprogram.org/pdf/228-235-g.pdf 97. Boudreaux, E.D., Baumann, B.M., Foulds, J. Camargo, C.A., Jr., Ziedonis, D. The effect of removing cost as a barrier to treatment initiation with an outpatient tobacco dependence clinic among emergency department patients. Academic Emergency Medicine 13:S373, 2006. 98. Steinberg, M.L., Krejci, J.A., Collett, K., Brandon, T.H., Ziedonis, D.M., Chen, K. Relationship between self-reported task persistence and history of quitting smoking, plans for quitting smoking, and current smoking status in adolescents. Addictive Behavior. Nov 22, 2006 [Epub ahead of print]. 32(7)1451-1460, 2007. 99. Fuller, B.E., Guydish, J., Tsoh, J., Reid, M.S., Resnick, M., Zammarelli, L., Ziedonis, D.M., Sears, C., McCarty, D. Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. J Subst Abuse Treat 32(1):53-60, Jan. 2007. Douglas M. Ziedonis, MD, MPH 37

100. Gerwe, C.F. and Ziedonis, D.M. Using the Orchestration Group Process of the Gerwe- Orchestration Method in Group Therapy for Addiction and Recovery. Journal of Groups in Addiction and Recovery 2(1): 41-66 2007. 101. Kim, S.S., Ziedonis, D.M. and Chen, K.W. Tobacco use and dependencies in Asian Americans: A review of the literature. Nicotine and Tobacco Research 9:169-184, 2007. 102. Ziedonis, D.M., Dual Diagnosis: The Evolving Conceptual Framework, Stohler, R., and Rossler, W., (eds.): Basel, Switzerland. S. Karger AG, 2005, Psychiatric Services, 58(3) 416, March 2007. 103. Ziedonis, D.M., Parks, J., Hanos Zimmermann, M., McCabe, P. Program and System Level Interventions to Address Tobacco Amongst Individuals with Schizophrenia. Journal of Dual Diagnosis 3(3/4): 151-175, 2007. 104. Epstein, E.E., McCrady, B., Morgan, T.J., Cook, S.M., Kugler, G., Ziedonis, D.M. The Successive Cohort Design: A Model for Developing New Behavioral Therapies for Drug Use Disorders and Application to Behavioral Couple Treatment. Addictive Disorders and Their Treatment, 6(1):1-19, 2007 105. Epstein, E.E., McCrady, B., Morgan, T.J., Cook, S.M., Kugler, G., Ziedonis, D.M. Couples Treatment for Drug Dependent Males: Preliminary Efficacy of a Stand Alone Outpatient Model. Addictive Disorders and Their Treatment, 6(1):21-37, 2007 106. Smelson, D.A., Losonczy, M.F., Ziedonis, D.M., Sussner, B.D., Castles-Fonseca, K., Rodrigues, S., and Kline, S. A brief community linkage intervention for veterans with a persistent mental illness and a co-occurring substance abuse disorder. European Journal of Psychiatry 21(2), 143-152, 2007. 107. Ziedonis, D.M, Zammarelli, L., Seward, G., Oliver, K., Guydish, J., Hobart, M., Meltzer, B. Addressing Tobacco Use Through Organizational Change: A Case Study of an Addiction Treatment Organization. Journal of Psychoactive Drugs, 39 (4), 451-459, 2007. Retrieved from http://www.ncbi.nim.nih/gov/pmc/articles/pmc2981503/?tool=pubmed. doi: 10.1080/02791072.2007.10399884 108. Williams, J.M., Gandhi, K.K., Steinberg, M.L., Foulds, J., Ziedonis, D.M., Benowitz, N.L. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine & Tobacco Research, 9 (8), 873-881, 2007. 109. Boudreaux, E.D., Baumann, B.M., Camargo, C.A., Jr., O Hea, E.L., Ziedonis, D.M. Changes in smoking associated with an acute health event: Theoretical and practical implications. Annals of Behavioral Medicine, 33:189-199, 2007. 110. Kim S.S., Ziedonis, D., Chen, K. Tobacco Use and Dependence in Asian American and Pacific Islander Adolescents: A Review of the Literature. Journal of Ethnicity in Substance Abuse. 6(3/4):113-142, 2007. Douglas M. Ziedonis, MD, MPH 38

111. Boudreaux, E.D., Baumann, B., Perry, J., Marks, D., Francies S., Velazaquez, M., Reinglass, A, Camargo, C., Ziedonis, D. Emergency department initiated tobacco interventions. Annals of Behavioral Medicine, 33:S098, 2007. 112. Huang, F.Y., Ziedonis, D.M., Hu, H.M., and Kline, A. Using Information Technology to Evaluate the Detection of Co-Occurring Substance Use Disorders Amongst Patients in a State Mental Health System: Implications for Co-Occurring Disorder State Initiatives, Community Mental Health Journal 44:11-27, 2008. 113. Ross, S., Cidambi, I., Dermatis, H., Weinstein, J., Ziedonis, D.M., Roth, S., Galanter, M. Music Therapy: A Novel Motivational Approach for Dually Diagnosed Patients. Journal of Addictive Diseases, 27:(1) 41-53, 2008 114. Kim, S., Kwon, M-S., Klessig, Y.C., and Ziedonis, D.M. Adapting Tobacco Dependence Group Therapy Treatment for Korean Americans: A Case Report of Pilot Treatment Program. Journal of Groups in Addiction & Recovery Therapy 3(1-2), 93-108, 2008. 115. Boudreaux, E.D., Baumann, B.M., Marks, D., Francies, S., Ziedonis, D. Polysubstance abuse, readiness to quite, and interest in ED-initiated interventions among adult emergency department patients. Academic Emergency Medicine, 15:S166, 2008. 116. Boudreaux, E.D., Baumann, B.M., Perry, J., Marks, D., Francies S., Camargo, C..A., Jr., Ziedonis, D.M. Emergency Department Initiated Treatments for Tobacco (EDITT): A pilot study. Annals of Behavioral Medicine, Dec; 36(3):314-25, 2008. 117. Ziedonis, D., Hitsman, B., Beckham, J.C., Zvolensky, M., Adler, L.E., Audrain- McGovern, J., Breslau, N., Brown, R.A., George, T.P., Williams, J., Calhoun, P.S., Riley, W.T. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine & Tobacco Research, Dec 10(12):1691-715, 2008. 118. Ziedonis, D.M., Amass, L., Steinberg, M.L., Krejci, J., Woody, G., Annon, J., Cohen, A.J., Waite-O Brien, N., Stine, S., McCarty, D., Reid, M., Brown, L., Maslansky, R., Winhusen, T., Babcock, D., Brigham, G., Muir, J., Orr, D., Buchan, B.J., Horton, T., and Ling, W. Predictors of Outcome For Short-Term Medically Supervised Opioid Withdrawal during a Randomized, Multi Center Trial of Buprenorphine-Naloxone and Clonidine in the NIDA Clinical Trials Network Drug and Alcohol Dependence. Drug Alcohol Depend. (Epub 2008 Sep 20). 99:28-36, 2009. 119. George, T. and Ziedonis, D. Addressing tobacco dependence in psychiatric practice: Promises and pitfalls. Canadian Journal of Psychiatry, 54(6): p. 137-139, 2009. 120. Williams, J.M., Ziedonis, D.M., Vreeland, B., Speelman-Edwards, N., Zechner, Michelle R., Williams, M.T., Rahim, R., Karmi, L., Molnar, M., and Eilers, R. A Wellness Approach to Addressing Tobacco in Mental Health Settings: Learning About Healthy Living. American Journal of Psychiatric Rehabilitation 12:4, 352-369, 2009 121. Guydish, J. and Ziedonis, D. Introduction to the Theme Issue on Smoking and Substance Abuse. Journal of Drug Issues 39: 245-256, 2009. Douglas M. Ziedonis, MD, MPH 39

122. Gardner, P.D, Tapper, A.R., King, J.A., Ziedonis, D.M. The Neurobiology of Nicotine Addiction: Clinical and Public Policy Implications. Journal of Drug Issues. 39: 1045-1067, 2009. 123. Kalman D, Kim, S. DiGirolamo, G., Smelson, D., Ziedonis, D. Addressing tobacco use disorder in smokers in early remission from alcohol dependence: The case for integrating smoking cessation services in substance use disorder treatment programs. Clinical Psychology Review 2010 Feb;30 (1):12-24. 124. DiFranza J, Ursprung WW, Lauzon B, Bancej C, Wellman RJ, Ziedonis D, Kim SS, Gervais A, Meltzer B, McKay CE, O'Loughlin J, Okoli CT, Fortuna LR, Tremblay M. A systematic review of the diagnostic and statistical manual diagnostic criteria for nicotine dependence. Addictive Behaviors. (Epub 2009 Dec 21). 35(5):373-82. 2010 125. Guydish, J., Tajima B., Chan, M., Delucchi, K.L., Ziedonis, D. Measuring smoking knowledge, attitudes and services (S-KAS) among clients in addiction treatment. Drug Alcohol Dependence 114(2-3):237-41, 2011. 126. Williams, J.M, Steinberg, M.L., Zimmermann, M.H., Gandhi, K.K., Stipelman, B, Budsock, P.D., Ziedonis, D.M. Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder. Journal Substance Abuse Treatment. 38(4): 384-93, 2010. 127. Boyer, E.W., Smelson, D., Fletcher, R., Ziedonis, D.M., Picard, R.W. Wireless Technologies, ubiquitous Computing and Mobile Health: Application to Drug Abuse Treatment and compliance with HIV Therapies. Journal of Medical Toxicology 2010 Jun 6(2)L 212-6, in process 128. Chen, K.W., Comerford, A., Shinnick P., Ziedonis, D.M. Introducing qigong meditation into residential addiction treatment: a pilot study where gender makes a difference. Journal of Alternative Complementary Medicine 2010 Aug: 16(8):875-82, in process. 129. Boudreaux, E.D., Moon, S., Baumann, B.M., Camargo, C.A., Jr., O Hea, E., Ziedonis, D.M. Intentions to Quit Smoking: Causal Attribution. Perceived Illness Severity, and Event-Related Fear During an Acute Health Event. Annals of Behavioral Medicine 2010; 40:350-355. doi:10.1007/s12160-010-9227-z 130. Wachholtz, A., Ziedonis, D., Gonzalez, G. Comorbid Pain and Opioid Addiction: Psychosocial and Pharmacological Treatments. Substance Use & Misuse, Early Online:1-17, 2011. 131. Wachholtz, A., Gonzalez, G., Boyer, E., Rosenbaum, C., & Ziedonis, D. The intersection of chronic pain treatment and opioid analgesic misuse: A review of the causes, treatments, and policy strategies. Substance Abuse and Rehabilitation Review. 2011; 2: 145-162. 132. Ozhathil, D., Abar, B., Baumann, B.M., Camargo, C.A., Ziedonis, D., & Boudreaux, E.D. The effect of removing cost as a barrier to treatment initiation with an outpatient tobacco dependence clinic among emergency department patients. Academic Emergency Medicine, 2011; 19(6): 662-664. Douglas M. Ziedonis, MD, MPH 40

133. Abar, B, Baumann, B.M., Rosenbaum, C., Boyer, E., Ziedonis, D, Boudreaux, E.D. Brief Report: Profiles of importance, readiness, and confidence in quitting tobacco use. Journal of Substance Use. Posted online October 2011. doi:10.3109/14659891.2011.606351 134. Guydish J, Ziedonis D, Tajima B, Seward G, Passalacqua E, Chan M, Delucchi K, Zammarelli L, Levy M, Kolodziej M, Brigham G. Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settings. Drug Alcohol Depend. 2012 Feb 1;121(1-2):30-7. 135. Guydish J, Tajima B, Kulaga A, Zavala R, Brown LS, Bostrom A, Ziedonis D, Chan M. The New York Policy on Smoking in Addiction Treatment: Findings After 1 Year. Am J Public Health. 2012 May;102(5):e17-e25. Epub 2012 Mar 15. 136. Kim, S.S., Chen, W., Kolodziej, M., Wang, X., Wang, V.J., Ziedonis, D. A Systematic Review of Smoking Cessation Intervention Studies in China. Nicotine & Tobacco Research. 2012, 14(8):891-899, doi: 10.1093/ntr/ntr289. 137. Boyer EW, Fletcher R, Fay RJ, Smelson D, Ziedonis D, Picard RW. Preliminary efforts directed toward the detection of craving of illicit substances: the iheal project. J Med Toxicol. 2012 Mar;8(1):5-9. 138. Smelson, D., Kalman, D., Losonczy, M.F., Kline, Al, Sambamoorthi, U., Hill, L.S., Castles-Fonesca, K., Ziedonis, D.M. A Brief Treatment Engagement Intervention for Individuals with Co-occurring Mental Illness and substance Use Disorders: Results of Randomized Clinical Trial. Community Mental Health Journal. 2012 Apr;48(2):127-32 139. Ziedonis, D., Wang, X., Li, T., Kim, S. S., Tonelli, M., Li, S., & Kalman, D. Addressing tobacco through organizational change in West China Hospital s Mental Health Center: The intervention and lessons learned in an implementation study. Journal of Dual Diagnosis. 8(2), 148-57.2012. DOI:10.1080/15504263.2012.672116 140. Mistler, L.A., Brunette, M.F., Ferron, J.C., & Ziedonis, D. Shared Decision Making and Tobacco Dependence Treatment for People with Severe Mental Illnesses. Journal of Dual Diagnosis. 8(2), 99-103, 2012 DOI: 10.1080/15504263.2012.671093 141. Ziedonis, D. & Kolodziej, M. E. Introduction to the Special Issue: Innovative Interventions for Treating Tobacco Addiction amongst Persons with Co-occurring Mental Illness and Addiction: New Approaches to Improve Outcomes. Journal of Dual Diagnosis. 8(2), 85-88, 2012 DOI 10.1080/15504263.2012.672159 142. Kim, S. S., Fang, H., DiFranza, J., Ziedonis, D., & Ma, G. Gender differences in the Fagerström Test for Nicotine Dependence in Korean Americans. Journal of Smoking Cessation. 7(1), 1-6, 2012 DOI: 10.1017/jsc.2012.5 143. Byatt, N. Moore Simas, T. A. Lundquist, R. S., Johnson, J. V., & Ziedonis, D. M. Strategies for improving perinatal depression treatment in North American outpatient obstetric settings. Journal of Psychosomatic Obstetrics & Gynecology. 33(4), 143 161, 2012 DOI: 10.3109/0167482X.2012.728649 Douglas M. Ziedonis, MD, MPH 41

144. Byatt N, Biebel K, Lundquist R, Moore Simas T, Debourdes-Jackson G, Ziedonis D. Patient, Provider and System-level Barriers and Facilitators to Addressing Perinatal Depression. Journal of Reproductive and Infant Psychology. 2012, 30(5): 436-439. 145. Kim SS, Kim SH, Ziedonis D: Tobacco dependence treatment for Korean Americans: preliminary findings. J Immigr Minor Health. 2012 June; 14(3), 395-404. doi: 10.1007/s10903-011-9507-0. 146. Pating, DR, Miller, MM, Goplerud, E, Martin, J, Ziedonis, DM. New systems of care for substance use disorders: treatment, finance, and technology under health care reform. Psychiatr Clin North Am. 35(2), 327-356, 2012 doi: 10.1016/j.psc.2012.03.004 147. Smelson, D., Yu, L., Buyske, S., Gonzalez, G., Tischfield, J., Deutsch, C. K., & Ziedonis, D. Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cuereactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence. Am J Addict. 21(5), 411-415, 2012. doi: 10.1111/j.1521-0391.2012.00253.x 148. Byatt N, Biebel K, Debourdes-Jackson G, Lundquist R, Moore Simas T, Weinreb L, Ziedonis D. Community Mental Health Provider Reluctance to Provide Pharmacotherapy May Be a Barrier to Addressing Perinatal Depression: A Preliminary Study. Psychiatric Quarterly. 84(2), 169-174, 2013. doi: 10.1007/s11126-012-9236-0. 149. Smelson D, Chen KW, Ziedonis D, Andes K, Lennox A, Callahan L, Rodrigues S, Eisenberg D: A pilot study of Qigong for reducing cocaine craving early in recovery. J Alternative Complement Medicine. 19(2): 97-101, 2013. 150. Kim S, Lee H, Kiang P, Kalman D, Ziedonis DM: Factors associated with alcohol problems among Asian American college students: Gender, ethnicity, smoking and depressed mood. J Subst Use. 2013; epub ahead of print DOI: 10.3109/14659891.2012.709912 151. Byatt N, Biebel K, Friedman L, Debourdes-Jackson G, Ziedonis D. Barriers and Facilitators to Addressing Perinatal Depression in Pediatric Settings: Perspective of Postpartum Women. Archives of Women s Mental Health (in press). b. Articles under review: 152. Murphy, K.M., and Ziedonis D.M. Group Guided Imagery and Music (GIM) Therapy for Adults in Substance Abuse Treatment. A Pilot Randomized Study Demonstrating Feasibility and Improved Outcomes Journal of the Association for Music and Imagery (under review). 153. Kim, S. and Ziedonis, D.M. Factors Associated with Intentions to Quit Smoking in Korean Americans. Public Health Nursing (under review). 154. Byatt N., Biebel K., Debourdes-Jackson G., Ziedonis D. Barriers and Facilitators to Addressing Perinatal Depression in Pediatric Settings: Perspective of Postpartum Women. Archives of Women s Mental Health (under review). Douglas M. Ziedonis, MD, MPH 42

155. Fortuna, L.R.. Porche, M.V., Alam, N., Padilla, A., Ziedonis, D. A Pilot Study of Cognitive Behavioral Therapy for Co-occurring PTSD and Substance Use Disorders in Adolescents Depression and Anxiety (under review). 156. Li, M., Deng, W., Chen, Z., He, Z., Wang, Q., Huang, C., Jiang, L., Gong, Q., Ziedonis, D. M., King, J. A., Liang, Z., Han, Y., Li, Y., Lin, Y., Liu, X., Wang, Y., Ma, X., Zhang, N., Li, T. A Splitting Brain: Imbalanced Neural Networks in Schizophrenia. PLOS ONE (under review). Chapters in Books & Other 157. Ziedonis, D.M. Family Assessment and Therapy. UCLA Handbook of Psychiatry, Year Book Medical Publishers Inc., Chicago, 538-551, 1990. 158. Ziedonis, D.M. Comorbid Psychopathology and Cocaine Addiction. In Kosten TR and Kleber HD (eds). Clinician's Guide to Cocaine Addiction: Theory, Research and Treatment. Guilford Press, New York, NY, 337-360, 1992. 159. Sullivan, M. and Ziedonis, D.M. Treatment for Substance Abuse. In Sullivan EJ (ed.) Nursing Care of Clients With Substance Abuse. Mosby-Year Book, Inc., St. Louis, 71-101, 1995. 160. Ziedonis, D.M. Substance Abuse Prevention Strategies for Psychiatric Patients. In Coombs RH and Ziedonis DM (eds.) Handbook on Drug Abuse Prevention: A Comprehensive Strategy to Prevent the Abuse of Alcohol and Other Drugs. Allyn and Bacon, Boston 445-469. 1995. 161. Ziedonis, D.M. and Fisher, W. Motivation Based Assessment and Treatment of Substance Abuse in Patients with Schizophrenia. In The Hatherleigh Guide to Treating Substance Abuse (Part II). Hatherleigh Press, New York, NY 269-287, 1996. 162. Ziedonis, D.M. and D Avanzo, K. Schizophrenia and Substance Abuse. In Kranzler HR and Rounsaville BJ (eds.) Dual Diagnosis and Treatment: Substance Abuse and Comorbid Medical and Psychiatric Disorders. Marcel Deker: New York, N.Y. 427-465, 1998. 163. Ziedonis, D.M., Wyatt, S.A. and George, T.P. Current Issues in Nicotine Dependence and Treatment. In: McCance-Katz, E. and Kosten, T.R. New Treatments for Chemical Addictions. American Psychiatric Press Inc: Washington, D.C. 1-34, 1998. 164. Wyatt, S. and Ziedonis, D.M. Psychological and Psychiatric Consequences of Amphetamine Use. In Tarter, R.S., Ammerman, R.T., Ott, P.J. (eds.) Sourcebook on Substance Use and Abuse. Plenum Press, New York, NY: 1998. 165. Ziedonis, D.M., Farren, C.K., and George, T. Depression and Substance Abuse. In Tohen M (ed.) Comorbidity in Affective Disorders, Marcel Dekker, New York, NY, 27-56, 1999. 166. Ziedonis, D.M. and Wyatt, S.A. Psychosis and the Addicted Patient. In Miller N (ed.) Principles of Addiction Medicine, 2 nd Edition. New York, NY: American Society of Addiction Medicine, 1999. Douglas M. Ziedonis, MD, MPH 43

167. O Connor, P.G. and Ziedonis, D.M. Linkages Between Substance Abuse, Primary Care, and Mental Health Services. In Miller N (ed.) Principles of Addiction Medicine. New York, NY: American Society of Addiction Medicine. 1999. 168. Ziedonis, D.M. and Nickou, C. Substance Abuse in Patients with Schizophrenia. In Hwang M. (ed.) Schizophrenia and Co-morbid Conditions: Diagnosis and Treatment. Washington, DC: American Psychiatric Press Inc., 187-222, 2001. 169. Ziedonis, D.M., Krejci, J., and Atdjian, S. Integrating Medications and Psychotherapy in the Treatment of Alcohol, Tobacco and Other Drug Addictions. In Kay J (ed.) Integrated Treatment of Psychiatric Disorders (Volume 20). Washington DC: American Psychiatric Press Inc., 79-111, 2001. 170. Ziedonis, D.M. and Krejci, J. Pharmacotherapy in the treatment of Substance Use Disorders: One Tool in the Toolbox. In Robert Coombs (ed.) Addiction Recovery Tools: A Practical Handbook. Thousand Oaks, CA: Sage Publications, 81-98, 2001. 171. Krejci, J. and Ziedonis, D.M. Medications in the treatment of addiction: Workplace issues. In J. Zweben and S. Lambert (eds.) Addiction in the Workplace, Occupational Medicine: State of the Art Reviews. Philadelphia: Hanley and Belfus, 2002. 172. Ziedonis, D.M., Steinberg, M.L., Smelson, D.A. and Wyatt, S. Co-occurring addictive and psychotic disorders. In A.W. Graham, T.K. Schultz, M.F. Mayo-Smith, R.K. Ries and B.B. Wilford (eds.) Principles of Addiction Medicine, Third Edition. Chevy Chase, MD: American Society of Addiction Medicine, 1297-1320, 2003. 173. Ziedonis, D.M. and Krejci, J. Dual Recovery Therapy: Blending Psychotherapies for Depression and Addiction. In Westermeyer, J., Weiss, R., and Ziedonis, D.M. (eds.) Integrated Treatment for Mood and Substance Use Disorders. John Hopkins University Press, Baltimore, MD, 90 121, 2003. 174. Ziedonis, D.M. and Fiester, S. Substance Abuse: Nicotine Dependence (Chapter 59). In Tasman A (ed.) Psychiatry (2 nd Edition). John Wiley and Sons, London, UK. 2003. 175. Ziedonis, D.M., Steinberg, M.L., D Avanzo, K. and Smelson, D.A. Schizophrenia and substance abuse. In Kranzler, H.R. and Rounsaville, B.J. (eds.) Dual diagnosis and treatment: Substance abuse and comorbid medical and psychiatric disorders 2 nd Edition. Marcel Deker: New York, NY, 387-436, 2004. 176. Ziedonis, D.M., Williams, J., Steinberg, M.L., Smelson, D.A., Sussner, B., Foulds, J., Krejci, J., and Violette, N. Addressing Tobacco Dependence Amongst Individuals with a Psychiatric Disorder: A Neglected Epidemic of Major Clinical and Public Health Concern. In Isaacs SL (ed.) VA In the Vanguard: Building on Success in Smoking Cessation. Department of Veterans Affairs. 141-170, 2005. 177. Ziedonis, D., Yanos, P.T., Silverstein, S.M. Relapse Prevention for Schizophrenia. Therapist s Guide to Evidence-Based Relapse Prevention, Elsevier, 2007, Douglas M. Ziedonis, MD, MPH 44

178. Foulds, J., DeInevo, C., Ziedonis, D.M., Steinberg, M.B. Health Effects of Tobacco, Nicotine, and Exposure to Tobacco Smoke Pollution (Chapter 13). In Brick, J. (ed.) Handbook of the Medical Consequences of Alcohol and Drug Abuse (2 nd Edition). The Haworth Press, Taylor & Francis Group, New York and London, 423-460, 2008. 179. Ziedonis, D.M., Day, E., O Hea, E.L., Krejci, J., Berman, J.A., Smelson, D.A. Treatment of Co-Occurring Psychiatric and Substance Use Disorders. In Tyrer, P. and Silk, K. (eds.) Cambridge Handbook for Effective Treatments in Psychiatry, Cambridge University Press. 442-458, 2008. 180. Ziedonis, D.M., Berman J., Lehn, M.D., Coameco, S. Support Groups and Twelve-Step Programs in the Treatment of the Chronic Pain Patient. In Smith and Passik (eds.) Pain and Chemical Dependency, Oxford University Press, USA; First Edition; April 25, 2008. 181. Ziedonis, D.M., Steinberg, M., Smelson, D.A., and Wyatt, S.A. Co-Occurring Addiction and Psychotic Disorders. In Ries, R., Fiellin, D., Miller, S., Saitz, R. (eds). Principles of Addiction Medicine, 4 th Edition. New York, NY: American Society of Addiction Medicine, 1193-1209, 2009 182. Gonzalez, G., Miozzo, R. and Ziedonis, D. Substance Use Disorders. In Rothschild AJ (ed), for the Evidence-Based Guide to Antipsychotic Medications, American Psychiatric Publishing, Inc., Washington, DC, 125-144, 2010. 183. Kim, S.S., Kalman, D., Gonzalez, G., Ziedonis, D. Substance Use disorder among Immigrants in the United States. In Sher, L. and Vilens A. (eds.) Immigration and Mental Health: Stress, Psychiatric Disorders and Suicidal Behavior Among Immigrants and Refugees, 243-65. New York: Nova Science Publishers, 2010. 184. Ziedonis, Kalman, Johnson, Mistler. Nicotine Dependence Management. Chapter 36 in Lowinson and Ruiz s Substance Abuse: A Comprehensive Textbook. 5th Edition. Editors: Pedro Ruiz MD, Eric C. Strain. 2011. Lippincott Williams and Wilkins. Philadelphia. 185. Ziedonis, D., Bizamcer, A.N., Steinberg M.L., Wyatt, S.A. Smelson, D.A. Vaiana, A.D. Co-Occurring Addiction and Psychotic Disorders. In Cavacuita, C.A. (ed). Principles of Addiction Medicine: The Essentials, 4th Edition, Chapter 86, 2011 186. Williams JM, Delnevo C, & Ziedonis DM. The Unmet Needs of Smokers with Mental Illness or Addiction. In After Tobacco: What Would Happen If Americans Stopped Smoking? Bearman, Neckerman and Wright (Eds). Columbia University Press, 2011. 187. Ziedonis, D.M., Kalman, D., Kolodziej, M., Johnson, C.W., Kim. S. Tobacco Addiction and Psychological Co-morbidities. In Pagoto, Sherry (ed) Psychological Co-morbidities of Physical Illness: A Behavioral Medicine Perspective. pp. 207-232, 2011. 188. Royal College of Physicians, Royal College of Psychiatrists. Smoking and mental health. London: RCP. Royal College of Psychiatrists Council Report CR178 (Contributors: J. Williams, Q. Wu, D. M. Ziedonis), 2013. Douglas M. Ziedonis, MD, MPH 45

D. Books / Monographs: 189. Coombs, R.H. and Ziedonis, D.M. (eds). Handbook on Drug Abuse Prevention: A Comprehensive Strategy to Prevent the Abuse of Alcohol and Other Drugs. Allyn and Bacon. Boston. 1995. 190. American Psychiatric Association. Practice Guidelines for the Treatment of Patients With Nicotine Dependence. American Psychiatric Press Inc. Washington DC, 1996. (Work Group on Nicotine Dependence co-authors: Hughes, J.R., Fiester, S., Goldstein, M., Resnick, M., Rock, N., and Ziedonis, D.M.), 1996. 191. Krauss, M.L., Segal, S.R., Frantz, A.H., and Ziedonis, D.M. The Governor s Blue Ribbon Task Force on Substance Abuse Report. Hartford, CT. 1996. 192. Ziedonis, D.M. and Simsarian, J. Department of Mental Health and Addiction Services Dual Diagnosis Task Force Report. DMHAS: Hartford, CT. 1997. 193. Group for the Advancement of Psychiatry: Substance Abuse Work Group. Addiction Treatment: A Case Approach to Avoiding Pitfalls. APPI Press: Washington, DC, 1998. 194. Slade, J., Ziedonis, D.M., Lindberg, D., Order-Connors B, and Hoffman A. New Jersey Guidelines for Tobacco Dependence Treatment. DAS: Trenton, NJ. 2000. 195. Westermeyer, J., Weiss, R., and Ziedonis, D.M. Integrated Treatment for Mood and Substance Use Disorders. John Hopkins University Press, Baltimore, MD. 2003. 196. Center for Substance Abuse Treatment. Substance Abuse Treatment for Persons With Co- Occurring Disorders. Treatment Improvement Protocol (TIP) Series 42. DHHS Publication No. (SMA) 05-3992. Rockville, MD: Substance Abuse and Mental Health Services Administration, (Authors / Panelists: Sacks, S., Ries, R., McNelis, D.M., Mee-Lee, D., Sorenson, J.L., Ziedonis, D.M., Zweben, J.E., Blackmon, B., Cantu, S., Chichester, C.S., Clark, C., Cline, C.A., Daw, R., Ekleberry, S.C., Fujita, B.N., Gallant, L.E., Harle, M., Kirby, M.W., Minkoff, K., Najavits, L.M., and Soto, T.A.). 2005. 197. Committee on Smoking Cessation in Military Veteran Populations. Combating Tobacco Use in Military and Veteran Populations. Institute of Medicine of the National Academies: Washington, DC. (Committee members: Bondurant S, Benowitz N, Curry, S, Gritz E, Jacobson P, Kizer K, Klesges, R, Koh H, Mariner W, Martinez-Donate A, Meara E, Peterson A, Stillman F, Wyatt E, Ziedonis D). 2009. D. Behavioral Therapy Manuals: 198. Ziedonis, D.M. and D Avanzo, K. Dual Recovery Therapy for Schizophrenia and Cocaine Addiction. (unpublished, 1998) NIDA Behavioral Therapy Development Study Manual. Douglas M. Ziedonis, MD, MPH 46

199. Ziedonis, D.M. and Krejci, J. Dual Recovery Therapy: Supporting Integrated Recovery from Co-occurring Substance Abuse and Mental Disorders in Outpatient Substance Abuse Treatment Settings. (unpublished, 2004) SAMHSA Organizational Change Study Manual. 200. Ziedonis, D.M., Comerford, T., Violette, N., and Krejci, J. Addressing Mental Health Problems in Substance Abuse Treatment: A Guide to Developing Consultant-Integrated and Fully-Integrated Programs Manual. (unpublished, 2004) SAMHSA Organizational Change Study Manual.. 201. Ziedonis, D.M. and Krejci, J. Addressing Mental Health Problems in Substance Abuse Treatment: A Guide to Assessment and Treatment Planning for Substance Abuse Counselors - Clinician Guide. (unpublished, 2004) SAMHSA Organizational Change Study Manual. 202. Ziedonis, D.M. and Krejci, J. Addressing Mental Health Problems in Substance Abuse Treatment: A Guide to Assessment and Treatment Planning for Substance Abuse Counselors - Instructor Guide. (unpublished, 2004) SAMHSA Organizational Change Study Manual. 203. Ziedonis, D.M. and Krejci, J. Addressing Mental Health Problems in Substance Abuse Treatment: A Guide to Assessment and Treatment Planning for Substance Abuse Counselors - Self-study Clinician Guide. (unpublished, 2004) SAMHSA Organizational Change Study Manual. 204. Ziedonis, D.M. and Krejci, J. A Guide for Supervisors of Substance Abuse Counselors Using the Self-Study Clinician Guide. (unpublished, 2004) SAMHSA Organizational Change Study Manual 205. Krejci, J.A., Steinberg, M.L. and Ziedonis, D.M.(unpublished) Motivational interviewing in tobacco dependence Manual. NIDA Behavioral Therapy Development Study Manual. 206. Williams, J., Ziedonis, D., Speelman, N., Vreeland, B., Zechner, M.R., Rahim, R., O Hea, E.L. Learning About Healthy Living. Tobacco and You. New Jersey Division of Mental Health Services. 2005. 207. Williams, J., Ziedonis, D.M., Krejci, J.A., Steinberg, M.L., and Zimmerman, M. Medication Management For Schizophrenia and Tobacco Dependence. (unpublished) NIDA Behavioral Therapy Development Study Manual.. 208. Ziedonis, D.M., Krejci, J.A., Steinberg, M.L., and Williams, J.M. Treatment of Addiction to Nicotine In Schizophrenia: A Tobacco Dependence Treatment Manual for Therapists. (unpublished) NIDA Behavioral Therapy Development Study Manual. 209. Ziedonis, D.M., Krejci, J.A., O Hea, E.L., and Boudreaux, E.D. Motivation Based Recovery Oriented Therapy: A Therapist Manual for Addiction Counselors Treating Polydrug Addiction. (unpublished) NIDA Behavioral Therapy Development Study Manual. 210. Krejci, J.A. and Ziedonis, D.M.. Adapting Motivational Enhancement Therapy for Poly- Drug Addiction: A Therapist Manual for Addiction Counselors. (unpublished) NIDA Behavioral Therapy Development Study Manual. Douglas M. Ziedonis, MD, MPH 47

211. Fortuna, LR, Jankowski, MK, Rosenberg, H, Mueser, K, Vallejo, Z, Rosenberg, S, Ziedonis, D. (Unpublished). Cognitive Behavioral Therapy Integrated for PTSD and Substance Abuse for Adolescents NIDA Behavioral Therapy Development Study Manual. E. Organizational Change Manual 212. Ziedonis DM, et al. Addressing Tobacco Through Organizational Change. (Unpublished) NIDA Organizational Change Study Manual. F. Music CD 213. Ziedonis, D.M. and Clottey, K. The Journey. Mindfulness Music. (www.cdbaby.com/cd/ziedonis). World Music Native American Flute, African Hand drums, Balafon, and Latvian Kokle. 2004. G. Computer Programs 214. Krejci, J.A., Steinberg, M.L. and Ziedonis, D.M. Motivating Ambivalent Smokers to Quit (MASQ) for MS Excel 97 [computer program]. Piscataway, NJ, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Division of Addiction Psychiatry. 2001. 215. Steinberg, M.L., Krejci, J.A., Ziedonis, D.M., and Williams, J.M. A Personalized Assessment Feedback Report for Smokers with Schizophrenia for MS Excel and MS Word [computer program]. Piscataway, NJ, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Division of Addiction Psychiatry. 2003. Douglas M. Ziedonis, MD, MPH 48